2. Article

Rīkojums stājas spēkā 2013.gada 1.janvārī. Nacionālā veselības dienesta direktors M.Taube 1.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Kompensējamo zāļu sarakstā iekļautās zāles Zāļu vispārīgais nosaukums ATĶ kodi Zāļu identifikācijas Nr. Zāļu nosaukums Reģistrācijas apliecības īpašnieks Forma Stiprums (mg) Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar PVN 12% (Ls) Kompensācijas summa (Ls) Saraksta kategorija Zāļu pazīme References cena 100% 75% 50% 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Amantadinum N04BB01 I000284-01 PK-Merz 100mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 100 90 5,08 6,99 6,99 5,24 3,50 A PR Amisulpridum N05AL05 09-0354-02 Amisan 200mg PRO.MED.CS Praha a.s. tabletes 200 30 10,70 14,19 14,16 10,62 7,08 A Amlodipinum C08CA01 07-0348-02 Amlodipine Medochemie 5mg Medochemie Ltd. tabletes 5 50 1,60 2,30 2,30 1,73 1,15 A R C08CA01 07-0349-02 Amlodipine Medochemie 10mg Medochemie Ltd. tabletes 10 50 2,55 3,60 3,60 2,70 1,80 A R Atorvastatinum C10AA05 10-0488-07 Atorgamma 10mg Worwag Pharma GmbH & Co.KG apvalkotas tabletes 10 30 1,60 2,30 1,92 1,44 0,96 A C10AA05 12-0103-07 Atorvastatin Billev 20mg Billev Pharma Aps apvalkotas tabletes 20 30 1,38 1,99 1,99 1,49 1,00 A R C10AA05 10-0490-07 Atorgamma 40mg Worwag Pharma GmbH & Co.KG apvalkotas tabletes 40 30 3,36 4,74 3,75 2,81 1,88 A C10AA05 12-0035-07 Atorvastatin Actavis 80mg Actavis Group PTC ehf apvalkotas tabletes 80 30 7,29 9,83 7,32 5,49 3,66 A C10AA05 I000272-01 Sortis 80 ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 80 30 8,17 10,98 7,32 5,49 3,66 A P Betahistinum N07CA01 12-0005-04 Betahistine Actavis 24mg Actavis Group PTC ehf tabletes 24 50 5,56 7,60 5,80 4,35 2,90 A N07CA01 I000273-01 Betaserc 24mg ELPIS SIA (paralēlais importētājs) tabletes 24 60 7,20 9,72 6,96 5,22 3,48 A P N07CA01 11-0388-09 Vertimed 24mg Medochemie Ltd. tabletes 24 100 11,54 15,22 11,50 8,63 5,75 A Buspironum N05BE01 I000295-01 Spitomin 10mg ELPIS SIA (paralēlais importētājs) tabletes 10 60 3,00 4,27 4,27 3,20 2,14 A PR Calcipotriolum/ Betamethasonum D05AX52 12-0011-01 Daivobet 50mcg/0,5mg/g LEO Pharma A/S gels 0.05/0.5 mg/g 15g 7,31 9,87 9,87 7,40 4,94 B D05AX52 12-0011-02 Daivobet 50mcg/0,5mg/g LEO Pharma A/S gels 0.05/0.5 mg/g 30g 13,74 17,93 17,93 13,45 8,97 B Clopidogrelum B01AC04 09-0524-05 Clopidogrel Actavis 75mg Actavis Group PCT ehf apvalkotas tabletes 75 28 2,17 3,08 3,07 2,30 1,54 A Docetaxelum L01CD02 EU/1/09/611/001 Docetaxel Teva Teva Pharma B.V. koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai 20 1 19,00 24,28 24,28 18,21 12,14 A R L01CD02 EU/1/09/611/002 Docetaxel Teva Teva Pharma B.V. koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai 80 1 84,99 99,95 85,96 64,47 42,98 A Doxazosinum C02CA04 07-0031-03 Doxalfa 4mg Stada Arzneimittel AG ilgstošas darbības tabletes 4 28 3,87 5,41 5,05 3,79 2,53 A C02CA04 I000259-01 Cardura XL 4mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības tabletes 4 30 4,14 5,76 5,41 4,06 2,71 A P Escitalopramum N06AB10 11-0381-04 Escitalopram Portfarma 10mg Portfarma ehf apvalkotas tabletes 10 30 3,26 4,60 4,04 3,03 2,02 A N06AB10 11-0382-04 Escitalopram Portfarma 20mg Portfarma ehf apvalkotas tabletes 20 30 7,18 9,70 7,98 5,99 3,99 A Exemestanum L02BG06 10-0319-01 Exemestane Alvogen 25mg Alvogen IPCo S.a.r.l. apvalkotas tabletes 25 30 32,00 39,59 32,54 24,41 16,27 A Felodipinum C08CA02 I000265-01 Presid 5mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības tabletes 5 30 3,12 4,42 4,42 3,32 2,21 A PR Formoterolum R03AC13 07-0102-03 Atimos 12mcg Chiesi Pharmaceuticals GmbH aerosols inhalācijām, šķīdums 0.012mg devā 120 devas 21,90 27,72 27,72 20,79 13,86 A R Indapamidum C03BA11 03-0079-01 Proindap 2,5mg PRO.MED.CS Praha a.s. cietas kapsulas 2.5 30 0,93 1,36 1,36 1,02 0,68 A R Interferonum alfa natural L03AB01 09-0326-01 Multiferon 3 million IU Swedish Orphan Biovitrum International AB šķīdums injekcijām pilnšļircēs 3mlj SV/ 0.5ml 6 342,48 388,34 388,34 291,26 194,17 B Isosorbidi mononitratum C01DA14 98-0451-01 Monosan 20mg PRO.MED.CS Praha a.s. tabletes 20 30 0,87 1,27 1,27 0,95 0,64 A R C01DA14 98-0452-01 Monosan 40mg PRO.MED.CS Praha a.s. tabletes 40 30 1,65 2,36 2,36 1,77 1,18 A R Lamotriginum N03AX09 08-0374-08 Lamotrigine Ranbaxy 25mg Ranbaxy UK Ltd disperģējamas tabletes 25 30 1,02 1,49 1,49 1,12 0,75 A R N03AX09 08-0377-08 Lamotrigine Ranbaxy 200mg Ranbaxy UK Ltd disperģējamas tabletes 200 30 8,03 10,79 10,68 8,01 5,34 A Latanoprostum/ Timololum S01ED51 11-0262-02 Latira 50mcg/5mg/ml Teva Pharma B.V. acu pilieni, šķīdums 0.05/5mg/ml- 2.5ml 3 13,50 17,64 15,29 11,47 7,65 A Lercanidipinum C08CA13 12-0142-14 Kapidin 10mg Zentiva k.s. apvalkotas tabletes 10 28 2,08 2,97 2,74 2,06 1,37 A C08CA13 12-0143-14 Kapidin 20mg Zentiva k.s. apvalkotas tabletes 20 28 3,25 4,59 4,59 3,44 2,30 A R C08CA13 10-0159-10 Ledipin 20mg Teva Pharma B.V. apvalkotas tabletes 20 28 3,27 4,63 4,59 3,44 2,30 A Levetiracetamum N03AX14 EU/1/11/701/001 Levetiracetam Teva Teva Pharma B.V. apvalkotas tabletes 250 30 5,26 7,22 7,22 5,42 3,61 A R N03AX14 EU/1/11/701/008 Levetiracetam Teva Teva Pharma B.V. apvalkotas tabletes 500 30 10,33 13,73 13,73 10,30 6,87 A R N03AX14 EU/1/11/701/022 Levetiracetam Teva Teva Pharma B.V. apvalkotas tabletes 1000 30 20,27 25,79 25,79 19,34 12,90 A R Levomepromazinum N05AA02 I000251-01 Tisercin 25mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 25 50 1,69 2,42 2,42 1,82 1,21 A PR Linagliptinum/ Metforminum A10BD11 EU/1/12/780/020 Jentadueto Boehringer Ingelheim International GmbH apvalkotas tabletes 2.5/1000 60 28,94 36,00 36,00 27,00 18,00 A R Lisinoprilum/ Amlodipinum C09BB03 12-0105-01 Dironorm 20mg/5mg Gedeon Richter Plc. tabletes 20/5 30 4,32 5,99 5,99 4,49 3,00 A R Moxonidinum C02AC05 05-0022-01 Stadapress 0,4mg Stada Arzneimittel AG apvalkotas tabletes 0,4 30 4,18 5,81 5,51 4,13 2,76 A Natrii risedronatum M05BA07 11-0335-02 Melenor 35mg Medochemie Ltd. apvalkotas tabletes 35 12 12,70 16,65 16,65 12,49 8,33 A R Nitrendipinum C08CA08 09-0093-02 Nitresan 20mg PRO.MED.CS Praha a.s. tabletes 20 30 2,04 2,91 2,91 2,18 1,46 A R Olanzapinum N05AH03 09-0390-03 Lapozan 5mg Medochemie Ltd. mutē disperģējamas tabletes 5 50 7,12 9,62 9,62 7,22 4,81 A R N05AH03 09-0391-03 Lapozan 10mg Medochemie Ltd. mutē disperģējamas tabletes 10 50 13,59 17,75 17,75 13,31 8,88 A R N05AH03 09-0392-02 Lapozan 15mg Medochemie Ltd. mutē disperģējamas tabletes 15 30 11,93 15,70 15,69 11,77 7,85 A Olmesartanum/ Hydrochloro-thiazidum C09DA08 12-0178-03 Co-Olimestra 20mg/12,5mg KRKA d.d., Novo mesto apvalkotas tabletes 20/12.5 30 4,32 5,99 3,52 2,64 1,76 A C09DA08 12-0179-03 Co-Olimestra 20mg/25mg KRKA d.d., Novo mesto apvalkotas tabletes 20/25 30 5,21 7,16 5,73 4,30 2,87 A C09DA08 12-0180-03 Co-Olimestra 40mg/12,5mg KRKA d.d., Novo mesto apvalkotas tabletes 40/12.5 30 6,02 8,20 6,36 4,77 3,18 A C09DA08 12-0181-03 Co-Olimestra 40mg/25mg KRKA d.d., Novo mesto apvalkotas tabletes 40/25 30 6,87 9,30 7,88 5,91 3,94 A Oxaliplatinum L01XA03 11-0268-01 Oxaliplatin Actavis 5mg/ml Actavis Group PTC ehf koncentrāts infūziju šķīduma pagatavošanai 50mg/ 10ml 1 11,84 15,59 15,58 11,69 7,79 A L01XA03 11-0268-02 Oxaliplatin Actavis 5mg/ml Actavis Group PTC ehf koncentrāts infūziju šķīduma pagatavošanai 100mg/ 20ml 1 21,20 26,89 26,87 20,15 13,44 A Peginterferonum alfa-2a + Ribavirinum L03AB11+ J05AB04 EU/1/02/221/014 + 04-0356-04 Pegasys 180mcg/0,5ml Nr.1 (4 oriģ.) + Copegus 200mg Nr.168 (1 oriģ.) Roche Registration Limited + Roche Latvija SIA šķīdums injekcijām pildspalvveida pilnšļircēs + apvalkotas tabletes 0.18mg/ 0.5ml + 200mg 1 kompl. 521,66 589,02 589,02 441,77 294,51 B Perindoprilum/ Indapamidum C09BA04 10-0235-04 Co-Perineva 2mg/0,625mg KRKA d.d., Novo mesto tabletes 2/0.625 30 1,58 2,27 2,22 1,67 1,11 A C09BA04 12-0251-17 Co-Perindalon 2mg/0,625mg Sandoz d.d. tabletes 2/0.625 30 2,90 4,07 2,22 1,67 1,11 A C09BA04 10-0236-04 Co-Perineva 4mg/1,25mg KRKA d.d., Novo mesto tabletes 4/1.25 30 2,95 4,13 4,13 3,10 2,07 A R C09BA04 09-0016-04 Perindap 4mg/1,25mg Ratiopharm GmbH tabletes 4/1.25 30 3,52 4,95 4,13 3,10 2,07 A C09BA04 12-0252-16 Co-Perindalon 4mg/1,25mg Sandoz d.d. tabletes 4/1.25 30 4,00 5,58 4,13 3,10 2,07 A C09BA04 11-0058-04 Co-Perineva 8mg/2,5mg KRKA d.d., Novo mesto tabletes 8/2.5 30 4,22 5,87 5,16 3,87 2,58 A Pioglitazonum A10BG03 EU/1/12/757/012 Pioglitazone Teva Teva Pharma B.V. tabletes 30 28 13,87 18,10 18,10 13,58 9,05 A R A10BG03 12-0083-02 Zipion 30mg Zentiva k.s. tabletes 30 28 14,54 18,92 18,10 13,58 9,05 A A10BG03 EU/1/12/757/022 Pioglitazone Teva Teva Pharma B.V. tabletes 45 28 23,86 30,02 27,09 20,32 13,55 A A10BG03 EU/1/12/757/002 Pioglitazone Teva Teva Pharma B.V. tabletes 15 28 10,30 13,70 13,70 10,28 6,85 A R Ramiprilum/ Amlodipinum C09BB07 12-0136-02 Ramdacordia 5mg/5mg Sandoz d.d. cietas kapsulas 5/5 30 2,61 3,67 3,67 2,75 1,84 A R C09BB07 12-0137-02 Ramdacordia 5mg/10mg Sandoz d.d. cietas kapsulas 5/10 30 3,26 4,60 4,60 3,45 2,30 A R C09BB07 12-0138-02 Ramdacordia 10mg/5mg Sandoz d.d. cietas kapsulas 10/5 30 4,00 5,58 5,58 4,19 2,79 A R C09BB07 12-0139-02 Ramdacordia 10mg/10mg Sandoz d.d. cietas kapsulas 10/10 30 4,53 6,27 6,27 4,70 3,14 A R Repaglinidum A10BX02 10-0105-01 Repaglinide Portfarma 1mg Portfarma ehf tabletes 1 90 6,84 9,26 9,26 6,95 4,63 A R A10BX02 10-0106-01 Repaglinide Portfarma 2mg Portfarma ehf tabletes 2 90 9,23 12,33 12,33 9,25 6,17 A R Risperidonum N05AX08 07-0207-03 Medorisper 2mg Medochemie Ltd. apvalkotas tabletes 2 30 3,77 5,28 5,28 3,96 2,64 A R N05AX08 07-0209-03 Medorisper 4mg Medochemie Ltd. apvalkotas tabletes 4 30 7,83 10,53 10,53 7,90 5,27 A R Rosuvastatinum C10AA07 12-0098-03 Rosuvastatin Actavis 10mg Actavis Group PTC ehf apvalkotas tabletes 10 30 2,41 3,40 2,94 2,21 1,47 A C10AA07 12-0098-05 Rosuvastatin Actavis 10mg Actavis Group PTC ehf apvalkotas tabletes 10 60 4,78 6,60 5,82 4,37 2,91 A C10AA07 12-0099-03 Rosuvastatin Actavis 20mg Actavis Group PTC ehf apvalkotas tabletes 20 30 4,89 6,74 5,58 4,19 2,79 A C10AA07 12-0099-05 Rosuvastatin Actavis 20mg Actavis Group PTC ehf apvalkotas tabletes 20 60 9,83 13,10 11,04 8,28 5,52 A Saxagliptinum/ Metforminum A10BD10 EU/1/11/731/003 Komboglyze Bristol-Myers Squibb Pharma/ AstraZeneca EEIG apvalkotas tabletes 2.5/850 60 27,04 33,76 33,76 25,32 16,88 A R A10BD10 EU/1/11/731/009 Komboglyze Bristol-Myers Squibb Pharma/ AstraZeneca EEIG apvalkotas tabletes 2.5/1000 60 27,04 33,76 33,76 25,32 16,88 A R Sevelamerum V03AE02 EU/1/99/123/008 Renagel Genzyme Europe B.V. apvalkotas tabletes 800 180 104,55 121,86 121,86 91,40 60,93 B V03AE02 EU/1/09/521/003 Renvela Genzyme Europe B.V. apvalkotas tabletes 800 180 104,55 121,86 121,86 91,40 60,93 B Tolperisonum M03BX04 I000275-01 Mydocalm 150mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 150 30 2,12 3,01 3,01 2,26 1,51 A PR Trandolaprilum C09AA10 08-0198-02 Gopten 4mg Abbott Laboratories Baltics SIA cietas kapsulas 4 56 8,54 11,45 11,45 8,59 5,73 B Urofollitropinum G03GA04 08-0085-02 Bravelle 75IU Ferring Lääkkeet Oy pulveris ar šķīdinātāju injekciju šķīduma pagatavošanai 75IU 10 130,30 150,70 150,70 113,03 75,35 B Nacionālā veselības dienesta direktors M.Taube 2.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Kompensējamo zāļu sarakstā iekļautās medicīniskās ierīces Medicīniskā ierīce Identifikācijas nr. Medicīniskās ierīces nosaukums Iesniedzējs Iepako-juma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar 12% PVN (Ls) Kompensācijas summa (Ls) Saraksta kategorija Pazīme References cena 100% 75% 50% Glikēmijas teststrēmeles 12/01-001/17-01 OneTouch Select Johnson&Johnson AB 50 7,78 10,47 10,47 7,85 5,24 A R Stomas aprūpes preces 12/04-005/14-01 Stomasafe josta S/M Linus Medical SIA 1 6,07 8,27 8,27 6,20 4,14 B 12/04-006/14-01 Stomasafe josta M/L Linus Medical SIA 1 6,07 8,27 8,27 6,20 4,14 B 12/04-007/14-01 Stomasafe josta L/XL Linus Medical SIA 1 6,07 8,27 8,27 6,20 4,14 B Nacionālā veselības dienesta direktors M.Taube 3.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta zālēm Zāļu vispārīgais nosaukums ATĶ kodi Zāļu identifikācijas Nr. Zāļu nosaukums Reģistrācijas apliecības īpašnieks Forma Stiprums (mg) Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar PVN 12% (Ls) Kompensācijas summa (Ls) Saraksta kategorija Zāļu pazīme References cena 100% 75% 50% 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Acidum ibandronicum M05BA06 EU/1/10/642/003 Ibandronic Acid Teva Teva Pharma B.V. apvalkota tablete 150 1 5,05 6,96 6,96 5,22 3,48 A R M05BA06 10-0149-01 Ossica 150mg Gedeon Richter Plc. apvalkota tablete 150 1 9,16 12,24 6,96 5,22 3,48 A M05BA06 EU/1/03/265/003 Bonviva Roche Registration Limited apvalkota tablete 150 1 11,50 15,18 6,96 5,22 3,48 A M05BA06 EU/1/10/642/004 Ibandronic Acid Teva Teva Pharma B.V. apvalkotas tabletes 150 3 14,87 19,33 19,33 14,50 9,67 A R M05BA06 EU/1/03/265/004 Bonviva Roche Registration Limited apvalkotas tabletes 150 3 36,82 45,26 19,33 14,50 9,67 A M05BA06 11-0313-01 Osagrand 3mg/3ml Zentiva k.s. šķīdums injekcijām 3mg/3ml 1 31,20 38,65 38,65 28,99 19,33 A R M05BA06 EU/1/03/265/005 Bonviva Roche Registration Limited šķīdums injekcijām pilnšļircē 3mg/3ml 1 40,71 49,84 38,65 28,99 19,33 A Acidum mycophenolicum L04AA06 EU/1/07/438/003 Myfenax Teva Pharma B.V. apvalkotas tabletes 500 50 33,35 41,18 41,18 30,89 20,59 A R L04AA06 08-0305-01 Mycophenolate Mofetil Sandoz 500mg Sandoz d.d. apvalkotas tabletes 500 50 37,28 45,80 41,18 30,89 20,59 A L04AA06 11-0129-01 Mycophenolate mofetil Ranbaxy 500mg Ranbaxy UK Ltd apvalkotas tabletes 500 50 37,29 45,81 41,18 30,89 20,59 A L04AA06 EU/1/96/005/002 CellCept Roche Registration Limited tabletes 500 50 37,71 46,31 41,18 30,89 20,59 A L04AA06 10-0534-01 Mycofenor 500mg Orion Corporation apvalkotas tabletes 500 50 39,69 48,63 41,18 30,89 20,59 A Amantadinum N04BB01 94-0219-02 PK-Merz 100mg Merz Pharmaceuticals GmbH apvalkotas tabletes 100 90 5,64 7,72 6,99 5,24 3,50 A Amisulpridum N05AL05 99-0625-01 Solian 200mg Sanofi-Aventis Latvia SIA tabletes 200 30 10,67 14,16 14,16 10,62 7,08 A R Amlodipinum C08CA01 07-0348-01 Amlodipine Medochemie 5mg Medochemie Ltd. tabletes 5 30 0,98 1,42 1,42 1,07 0,71 A R C08CA01 08-0357-04 Amlodipine Teva 5mg Teva Pharma B.V. tabletes 5 30 0,99 1,44 1,42 1,07 0,71 A C08CA01 06-0181-02 Agen 5mg Zentiva a.s. tabletes 5 30 1,21 1,75 1,42 1,07 0,71 A C08CA01 11-0280-01 Amlodipine Vitabalans 5mg Vitabalans Oy tabletes 5 30 1,28 1,85 1,42 1,07 0,71 A C08CA01 07-0050-05 Amlocard B 5mg Hexal AG tabletes 5 30 1,43 2,06 1,42 1,07 0,71 A C08CA01 07-0169-03 Lofral 5mg Mepha Lda. tabletes 5 30 1,43 2,06 1,42 1,07 0,71 A C08CA01 04-0443-01 Tenox 5mg KRKA d.d., Novo mesto tabletes 5 30 1,43 2,06 1,42 1,07 0,71 A C08CA01 I000211-01 Norvasc 5mg Scandic Pharma SIA (paralēlais importētājs) tabletes 5 30 2,41 3,40 1,42 1,07 0,71 A P C08CA01 97-0600-01 Norvasc 5mg Pfizer Limited tabletes 5 30 2,68 3,77 1,42 1,07 0,71 A C08CA01 07-0349-01 Amlodipine Medochemie 10mg Medochemie Ltd. tabletes 10 30 1,56 2,24 2,24 1,68 1,12 A R C08CA01 08-0358-05 Amlodipine Teva 10mg Teva Pharma B.V. tabletes 10 30 1,61 2,31 2,24 1,68 1,12 A C08CA01 06-0182-02 Agen 10mg Zentiva a.s. tabletes 10 30 1,92 2,74 2,24 1,68 1,12 A C08CA01 11-0281-01 Amlodipine Vitabalans 10mg Vitabalans Oy tabletes 10 30 1,92 2,74 2,24 1,68 1,12 A C08CA01 07-0052-05 Amlocard B 10mg Hexal AG tabletes 10 30 2,30 3,26 2,24 1,68 1,12 A C08CA01 07-0170-01 Lofral 10mg Mepha Lda. tabletes 10 30 2,30 3,26 2,24 1,68 1,12 A C08CA01 97-0601-01 Norvasc 10mg Pfizer Limited tabletes 10 30 2,68 3,77 2,24 1,68 1,12 A C08CA01 04-0444-01 Tenox 10mg KRKA d.d., Novo mesto tabletes 10 30 2,68 3,77 2,24 1,68 1,12 A Amlodipinum/ Atorvastatinum C10BX03 06-0020-01 CADUET 5mg/10mg Pfizer Europe MA EEIG apvalkotas tabletes 5/10 30 6,48 8,79 3,33 2,50 1,67 A C10BX03 06-0021-01 CADUET 10mg/10mg Pfizer Europe MA EEIG apvalkotas tabletes 10/10 30 6,60 8,95 4,17 3,13 2,09 A Amlodipinum/ Valsartanum C09DB01 EU/1/06/370/011 Exforge Novartis Europharm Limited apvalkotas tabletes 5/160 28 17,34 22,29 6,16 4,62 3,08 A C09DB01 EU/1/06/370/019 Exforge Novartis Europharm Limited apvalkotas tabletes 10/160 28 18,52 23,71 6,94 5,21 3,47 A Amlodipinum/ Valsartanum/ Hydrochloro-thiazidum C09DX01 EU/1/09/569/002 Exforge HCT Novartis Europharm Limited apvalkotas tabletes 5/160/ 12.5 28 17,68 22,70 7,56 5,67 3,78 A C09DX01 EU/1/09/569/014 Exforge HCT Novartis Europharm Limited apvalkotas tabletes 10/160/ 12.5 28 19,19 24,51 8,34 6,26 4,17 A Anastrozolum L02BG03 07-0287-05 Anastrozole-Teva 1mg Teva Pharma B.V. apvalkotas tabletes 1 28 11,00 14,56 14,56 10,92 7,28 A R L02BG03 07-0289-05 Anastrozole SanoSwiss 1mg SanoSwiss UAB apvalkotas tabletes 1 28 12,60 16,53 14,56 10,92 7,28 A L02BG03 08-0197-02 Axastrol 1mg Grindeks AS apvalkotas tabletes 1 28 12,69 16,64 14,56 10,92 7,28 A L02BG03 07-0288-05 Anastrozole Actavis 1mg Actavis Group PCT ehf apvalkotas tabletes 1 28 13,41 17,53 14,56 10,92 7,28 A L02BG03 11-0007-01 Anastrozole Orion 1mg Orion Corporation apvalkotas tabletes 1 28 20,19 25,70 14,56 10,92 7,28 A L02BG03 10-0276-05 Zenbrest 1mg Zentiva k.s. apvalkotas tabletes 1 30 21,80 27,60 15,60 11,70 7,80 A L02BG03 00-0466-01 Arimidex 1mg AstraZeneca UK Limited apvalkotas tabletes 1 28 28,15 35,07 14,56 10,92 7,28 A Atenololum C07AB03 00-1270-01 Atenodeks 50mg Grindeks AS apvalkotas tabletes 50 28 0,58 0,84 0,84 0,63 0,42 A R C07AB03 98-0170-01 Atenolol-ratiopharm 50mg Ratiopharm GmbH apvalkotas tabletes 50 30 0,68 0,99 0,90 0,68 0,45 A C07AB03 00-1271-01 Atenodeks 100mg Grindeks AS apvalkotas tabletes 100 28 1,25 1,80 1,64 1,23 0,82 A Atorvastatinum C10AA05 11-0041-07 Amicor 10mg Medochemie Ltd. apvalkotas tabletes 10 30 1,33 1,92 1,92 1,44 0,96 A R C10AA05 08-0379-07 Atilen 10mg Teva Pharma B.V. apvalkotas tabletes 10 30 1,36 1,96 1,92 1,44 0,96 A C10AA05 07-0112-07 Atorvastatin Actavis 10mg Actavis Group hf apvalkotas tabletes 10 30 1,51 2,17 1,92 1,44 0,96 A C10AA05 11-0164-04 Atorvastatin Portfarma 10mg Portfarma ehf apvalkotas tabletes 10 30 1,55 2,23 1,92 1,44 0,96 A C10AA05 03-0362-01 Atoris 10mg KRKA d.d., Novo mesto apvalkotas tabletes 10 30 1,96 2,80 1,92 1,44 0,96 A C10AA05 07-0171-07 Lopamol 10mg Gedeon Richter Plc. apvalkotas tabletes 10 30 2,29 3,25 1,92 1,44 0,96 A C10AA05 07-0174-07 Atorvastatin Polpharma 10mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 10 30 2,41 3,40 1,92 1,44 0,96 A C10AA05 10-0468-05 Tulip 10mg Sandoz d.d. apvalkotas tabletes 10 30 2,41 3,40 1,92 1,44 0,96 A C10AA05 05-0329-01 Torvacard 10mg Zentiva k.s. apvalkotas tabletes 10 30 2,73 3,84 1,92 1,44 0,96 A C10AA05 98-0598-01 Sortis 10mg Pfizer Limited apvalkotas tabletes 10 30 6,01 8,19 1,92 1,44 0,96 A C10AA05 I000219-01 Sortis 10 Scandic Pharma SIA (paralēlais importētājs) apvalkotas tabletes 10 30 6,22 8,46 1,92 1,44 0,96 A P C10AA05 10-0403-01 Sortis 10mg Pfizer Limited košļājamas tabletes 10 30 6,92 9,36 1,92 1,44 0,96 A C10AA05 11-0165-04 Atorvastatin Portfarma 20mg Portfarma ehf apvalkotas tabletes 20 30 1,62 2,33 1,99 1,49 1,00 A C10AA05 08-0380-07 Atilen 20mg Teva Pharma B.V. apvalkotas tabletes 20 30 1,71 2,45 1,99 1,49 1,00 A C10AA05 07-0113-07 Atorvastatin Actavis 20mg Actavis Group hf apvalkotas tabletes 20 30 1,72 2,46 1,99 1,49 1,00 A C10AA05 03-0363-01 Atoris 20mg KRKA d.d., Novo mesto apvalkotas tabletes 20 30 2,12 3,01 1,99 1,49 1,00 A C10AA05 11-0042-07 Amicor 20mg Medochemie Ltd. apvalkotas tabletes 20 30 2,26 3,20 1,99 1,49 1,00 A C10AA05 10-0489-07 Atorgamma 20mg Worwag Pharma GmbH & Co.KG apvalkotas tabletes 20 30 2,38 3,37 1,99 1,49 1,00 A C10AA05 07-0175-07 Atorvastatin Polpharma 20mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 20 30 3,52 4,95 1,99 1,49 1,00 A C10AA05 10-0469-04 Tulip 20mg Sandoz d.d. apvalkotas tabletes 20 30 3,53 4,96 1,99 1,49 1,00 A C10AA05 07-0172-07 Lopamol 20mg Gedeon Richter Plc. apvalkotas tabletes 20 30 3,64 5,11 1,99 1,49 1,00 A C10AA05 05-0330-01 Torvacard 20mg Zentiva k.s. apvalkotas tabletes 20 30 3,64 5,11 1,99 1,49 1,00 A C10AA05 98-0599-01 Sortis 20mg Pfizer Limited apvalkotas tabletes 20 30 6,01 8,19 1,99 1,49 1,00 A C10AA05 I000220-01 Sortis 20 Scandic Pharma SIA (paralēlais importētājs) apvalkotas tabletes 20 30 8,72 11,68 1,99 1,49 1,00 A P C10AA05 10-0404-01 Sortis 20mg Pfizer Limited košļājamas tabletes 20 30 10,50 13,94 1,99 1,49 1,00 A C10AA05 10-0605-01 Atoris 30mg KRKA d.d., Novo mesto apvalkotas tabletes 30 30 2,07 2,95 2,93 2,20 1,47 A C10AA05 11-0043-07 Amicor 40mg Medochemie Ltd. apvalkotas tabletes 40 30 2,67 3,75 3,75 2,81 1,88 A R C10AA05 08-0381-07 Atilen 40mg Teva Pharma B.V. apvalkotas tabletes 40 30 3,06 4,35 3,75 2,81 1,88 A C10AA05 07-0114-07 Atorvastatin Actavis 40mg Actavis Group hf apvalkotas tabletes 40 30 3,18 4,50 3,75 2,81 1,88 A C10AA05 11-0166-04 Atorvastatin Portfarma 40mg Portfarma ehf apvalkotas tabletes 40 30 3,42 4,82 3,75 2,81 1,88 A C10AA05 05-0169-01 Atoris 40mg KRKA d.d., Novo mesto apvalkotas tabletes 40 30 4,09 5,70 3,75 2,81 1,88 A C10AA05 07-0176-07 Atorvastatin Polpharma 40mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 40 30 6,07 8,27 3,75 2,81 1,88 A C10AA05 07-0173-07 Lopamol 40mg Gedeon Richter Plc. apvalkotas tabletes 40 30 6,88 9,31 3,75 2,81 1,88 A C10AA05 05-0331-01 Torvacard 40mg Zentiva k.s. apvalkotas tabletes 40 30 6,88 9,31 3,75 2,81 1,88 A C10AA05 98-0600-01 Sortis 40mg Pfizer Limited apvalkotas tabletes 40 30 9,69 12,92 3,75 2,81 1,88 A C10AA05 10-0606-01 Atoris 60mg KRKA d.d., Novo mesto apvalkotas tabletes 60 30 4,30 5,97 5,58 4,19 2,79 A C10AA05 10-0607-01 Atoris 80mg KRKA d.d., Novo mesto apvalkotas tabletes 80 30 8,60 11,52 7,32 5,49 3,66 A C10AA05 03-0502-01 Sortis 80mg Pfizer Limited apvalkotas tabletes 80 30 13,03 17,06 7,32 5,49 3,66 A Atorvastatinum/ Amlodipinum C10BX03 11-0287-01 Duplecor 10mg/5mg Gedeon Richter Plc. apvalkotas tabletes 10/5 30 4,52 6,26 3,33 2,50 1,67 A C10BX03 11-0286-01 Duplecor 10mg/10mg Gedeon Richter Plc. apvalkotas tabletes 10/10 30 5,45 7,47 4,17 3,13 2,09 A C10BX03 11-0289-01 Duplecor 20mg/5mg Gedeon Richter Plc. apvalkotas tabletes 20/5 30 5,26 7,22 3,39 2,54 1,70 A C10BX03 11-0288-01 Duplecor 20mg/10mg Gedeon Richter Plc. apvalkotas tabletes 20/10 30 7,18 9,70 4,23 3,17 2,12 A Betahistinum N07CA01 03-0317-02 Betaserc 24mg Abbott Healthcare Products B.V. tabletes 24 50 7,24 9,78 5,80 4,35 2,90 A N07CA01 07-0371-05 Polvertic 24mg Medana Pharma SA tabletes 24 60 6,77 9,17 6,96 5,22 3,48 A Betaxololum C07AB05 02-0230-01 Lokren 20mg Sanofi-Aventis Latvia SIA apvalkotas tabletes 20 28 2,53 3,57 2,02 1,52 1,01 A C07AB05 04-0209-01 Betac 20mg Medochemie Ltd. apvalkotas tabletes 20 30 2,58 3,64 2,16 1,62 1,08 A Bicalutamidum L02BB03 07-0110-06 Bicalutamid Actavis 50mg Actavis Group PCT ehf apvalkotas tabletes 50 28 16,60 21,40 21,40 16,05 10,70 A R L02BB03 07-0139-02 Bicalutamide Teva 50mg Teva Pharma B.V. apvalkotas tabletes 50 28 17,00 21,88 21,40 16,05 10,70 A L02BB03 98-0735-01 Casodex 50mg AstraZeneca UK Limited apvalkotas tabletes 50 28 54,88 66,23 21,40 16,05 10,70 A L02BB03 04-0314-01 Calumid 50mg Gedeon Richter Plc. apvalkotas tabletes 50 30 19,50 24,89 22,93 17,20 11,47 A L02BB03 07-0111-06 Bicalutamid Actavis 150mg Actavis Group PCT ehf apvalkotas tabletes 150 28 52,63 63,71 63,71 47,78 31,86 A R L02BB03 08-0037-02 Bicalutamide Teva 150mg Teva Pharma B.V. apvalkotas tabletes 150 28 54,35 65,63 63,71 47,78 31,86 A L02BB03 02-0267-01 Casodex 150mg AstraZeneca UK Limited apvalkotas tabletes 150 28 164,46 188,96 63,71 47,78 31,86 A Bimatoprostum S01EE03 EU/1/02/205/001 Lumigan Allergan Pharmaceuticals Ireland acu pilieni, šķīdums 0.3mg/ml-3ml 1 gab. 8,68 11,63 4,02 3,02 2,01 A S01EE03 EU/1/02/205/002 Lumigan Allergan Pharmaceuticals Ireland acu pilieni, šķīdums 0.3mg/ml-3ml 3 gab. 22,66 28,60 12,01 9,01 6,01 A Bimatoprostum/ Timololum S01ED51 EU/1/06/340/001 Ganfort Allergan Pharmaceuticals Ireland acu pilieni, šķīdums 0.3/5mg/ ml-3ml 1 gab. 9,43 12,59 5,12 3,84 2,56 A S01ED51 EU/1/06/340/002 Ganfort Allergan Pharmaceuticals Ireland acu pilieni, šķīdums 0.3/5mg/ ml-3ml 3 gab. 27,71 34,55 15,29 11,47 7,65 A Bisoprololum C07AB07 03-0306-03 Bisoprolol-ratiopharm 10mg Ratiopharm GmbH tabletes 10 30 1,50 2,16 2,16 1,62 1,08 A R C07AB07 05-0292-01 Coronal 10mg Zentiva a.s. apvalkotas tabletes 10 30 1,58 2,27 2,16 1,62 1,08 A C07AB07 08-0338-04 Bisoprolol Vitabalans 10mg Vitabalans Oy tabletes 10 30 1,61 2,31 2,16 1,62 1,08 A C07AB07 04-0021-01 Bisogamma 10mg Worwag Pharma GmbH & Co.KG apvalkotas tabletes 10 30 1,92 2,74 2,16 1,62 1,08 A C07AB07 99-0011-01 Concor 10mg Merck KgaA apvalkotas tabletes 10 30 2,64 3,72 2,16 1,62 1,08 A Bisoprololum/ Amlodipinum C07FB07 11-0130-02 Concor AM 5mg/5mg Merck KgaA tabletes 5/5 30 4,74 6,55 2,76 2,07 1,38 A C07FB07 11-0132-02 Concor AM 5mg/10mg Merck KgaA tabletes 5/10 30 5,64 7,72 3,60 2,70 1,80 A C07FB07 11-0131-02 Concor AM 10mg/5mg Merck KgaA tabletes 10/5 30 5,64 7,72 3,57 2,68 1,79 A C07FB07 11-0133-02 Concor AM 10mg/10mg Merck KgaA tabletes 10/10 30 6,54 8,87 4,41 3,31 2,21 A Bisoprololum/ Hydrochloro-thiazidum C07BB07 03-0490-01 Lodoz 10mg/6,25mg Merck KgaA apvalkotas tabletes 10/6.25 30 4,41 6,12 2,91 2,18 1,46 A Candesartanum C09CA06 99-0118-01 Atacand 8mg AstraZeneca AB tabletes 8 28 10,83 14,35 2,55 1,91 1,28 A C09CA06 99-0119-01 Atacand 16mg AstraZeneca AB tabletes 16 28 12,95 16,97 4,85 3,64 2,43 A Carbamazepinum N03AF01 96-0437-01 Finlepsin 200mg Teva Pharma B.V. tabletes 200 50 1,66 2,39 2,39 1,79 1,20 A R N03AF01 00-0470-01 Carbalex 200mg G.L. Pharma GmbH tabletes 200 50 1,75 2,51 2,39 1,79 1,20 A N03AF01 97-0530-01 Tegretol CR 200mg Novartis Finland Oy ilgstošas darbības apvalkotas tabletes 200 50 2,68 3,77 2,87 2,15 1,44 A N03AF01 98-0383-01 Finlepsin 200mg Teva Pharma B.V. ilgstošas darbības tabletes 200 50 2,84 3,99 2,87 2,15 1,44 A Citalopramum N06AB04 06-0095-04 Citalopram-Teva 10mg Teva Pharma B.V. apvalkotas tabletes 10 30 1,76 2,52 1,96 1,47 0,98 A N06AB04 05-0462-01 Citalopram Actavis 20mg Actavis Nordic A/S apvalkotas tabletes 20 28 2,60 3,66 3,66 2,75 1,83 A R N06AB04 03-0309-01 Ciral 20mg Sandoz d.d. apvalkotas tabletes 20 28 3,83 5,35 3,66 2,75 1,83 A N06AB04 06-0059-02 Citalanorm Genericon 20mg Genericon Pharma GmbH apvalkotas tabletes 20 30 3,59 5,04 3,92 2,94 1,96 A N06AB04 06-0096-04 Citalopram-Teva 20mg Teva Pharma B.V. apvalkotas tabletes 20 30 3,59 5,04 3,92 2,94 1,96 A N06AB04 06-0198-02 Citalec 20mg Zentiva a.s. apvalkotas tabletes 20 30 7,22 9,74 3,92 2,94 1,96 A Clopidogrelum B01AC04 EU/1/09/553/003 Zyllt KRKA d.d., Novo mesto apvalkotas tabletes 75 28 2,16 3,07 3,07 2,30 1,54 A R B01AC04 09-0482-15 Platel 75mg Medochemie Ltd. apvalkotas tabletes 75 28 2,41 3,40 3,07 2,30 1,54 A B01AC04 10-0409-16 Clopidogrel GSK 75mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 75 28 2,42 3,42 3,07 2,30 1,54 A B01AC04 10-0166-05 Clopidogrel SanoSwiss 75mg SanoSwiss UAB apvalkotas tabletes 75 28 2,81 3,94 3,07 2,30 1,54 A B01AC04 10-0253-02 Glopenel 75mg Olainfarm A/S apvalkotas tabletes 75 28 3,05 4,33 3,07 2,30 1,54 A B01AC04 EU/1/09/540/002 Clopidogrel Teva Teva Pharma B.V. apvalkotas tabletes 75 28 4,99 6,88 3,07 2,30 1,54 A B01AC04 09-0443-14 Plavocorin 75mg Sandoz d.d. apvalkotas tabletes 75 28 5,31 7,29 3,07 2,30 1,54 A B01AC04 09-0371-05 Clopimef 75mg Mepha-Investigacao, Desenvolvimento e Fabricacao F apvalkotas tabletes 75 28 5,96 8,12 3,07 2,30 1,54 A B01AC04 EU/1/98/069/001a Plavix Sanofi Pharma Bristol-Myers Squibb SCN apvalkotas tabletes 75 28 6,77 9,17 3,07 2,30 1,54 A B01AC04 09-0257-01 Trombex 75mg Zentiva k.s. apvalkotas tabletes 75 30 3,39 4,78 3,29 2,47 1,65 A B01AC04 09-0371-10 Clopimef 75mg Mepha-Investigacao, Desenvolvimento e Fabricacao F apvalkotas tabletes 75 84 17,57 22,57 9,16 6,87 4,58 A B01AC04 EU/1/98/069/003a Plavix Sanofi Pharma Bristol-Myers Squibb SCN apvalkotas tabletes 75 84 19,92 25,38 9,16 6,87 4,58 A B01AC04 09-0257-02 Trombex 75mg Zentiva k.s. apvalkotas tabletes 75 90 10,85 14,38 9,81 7,36 4,91 A Clopidogrelum/ Acidum acetyl-salicylicum B01AC30 EU/1/10/619/009 DuoPlavin Sanofi Pharma Bristol-Myers Squibb SCN apvalkotas tabletes 75/100 28 6,77 9,17 3,07 2,30 1,54 A Cyproteronum G03HA01 00-0838-01 Cyproplex 50mg Teva Pharma B.V. tabletes 50 50 11,85 15,61 15,61 11,71 7,81 A R G03HA01 11-0322-04 Imvel 50mg Elvim Ltd. tabletes 50 50 13,25 17,34 15,61 11,71 7,81 A G03HA01 I000205-01 Androcur 50 Scandic Pharma SIA (paralēlais importētājs) tabletes 50 50 14,38 18,73 15,61 11,71 7,81 A P G03HA01 95-0266-03 Androcur 50mg Bayer Pharma AG tabletes 50 50 14,41 18,76 15,61 11,71 7,81 A Docetaxelum L01CD02 10-0578-01 Camitotic 20mg/ml Actavis Group PCT ehf koncentrāts infūziju šķīduma pagatavošanai 20mg/ml 1 20,22 25,74 24,28 18,21 12,14 A L01CD02 10-0579-01 Docetaxel Actavis 20mg/0,5ml Actavis Group PCT ehf koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai 20mg/ 0.5ml 1 20,22 25,74 24,28 18,21 12,14 A L01CD02 EU/1/95/002/003 Taxotere Aventis Pharma S.A. koncentrāts infūziju šķīduma pagatavošanai 20mg/ml 1 67,00 79,80 24,28 18,21 12,14 A L01CD02 10-0578-02 Camitotic 20mg/ml Actavis Group PCT ehf koncentrāts infūziju šķīduma pagatavošanai 80mg/ 4ml 1 72,50 85,96 85,96 64,47 42,98 A R L01CD02 10-0580-01 Docetaxel Actavis 80mg/2ml Actavis Group PCT ehf koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai 80mg/ 2ml 1 72,51 85,97 85,96 64,47 42,98 A L01CD02 EU/1/95/002/004 Taxotere Aventis Pharma S.A. koncentrāts infūziju šķīduma pagatavošanai 80mg/ 4ml 1 241,00 274,68 85,96 64,47 42,98 A Dorzolamidum S01EC03 11-0010-01 Dorzolamide Actavis Actavis Group PCT ehf acu pilieni, šķīdums 20mg/ml-5ml 1 gab. 3,10 4,40 4,40 3,30 2,20 A R S01EC03 11-0011-01 Dorzolamide Portfarma 20mg/ml Portfarma ehf acu pilieni, šķīdums 20mg/ml-5ml 1 gab. 3,52 4,95 4,40 3,30 2,20 A S01EC03 11-0014-01 Oftidor 20mg/ml Sanitas AB acu pilieni, šķīdums 20mg/ml-5ml 1 gab. 3,73 5,22 4,40 3,30 2,20 A S01EC03 98-0168-01 Trusopt 20mg/ml SIA "Merck Sharp & Dohme Latvija" acu pilieni, šķīdums 20mg/ml-5ml 1 gab. 4,43 6,14 4,40 3,30 2,20 A Dorzolamidum/ Timololum S01ED51 I000236-01 Cosopt 20mg/ml + 5mg/ml Scandic Pharma SIA (paralēlais importētājs) acu pilieni, šķīdums 20/5mg/ ml-5ml 1 gab. 7,05 9,53 5,49 4,12 2,75 A P S01ED51 99-0966-02 Cosopt 20mg/5mg/ml SIA "Merck Sharp & Dohme Latvija" acu pilieni, šķīdums 20/5mg/ ml-5ml 1 gab. 7,13 9,63 5,49 4,12 2,75 A S01ED51 99-0966-01 Cosopt 20mg/5mg/ml SIA "Merck Sharp & Dohme Latvija" acu pilieni, šķīdums 20/5mg/ ml-5ml 3 gab. 18,09 23,20 16,38 12,29 8,19 A Doxazosinum C02CA04 09-0214-02 Doxazosin Actavis 4mg Actavis Group PCT ehf ilgstošas darbības tabletes 4 30 3,87 5,41 5,41 4,06 2,71 A R C02CA04 01-0181-01 Kamiren 4mg KRKA d.d., Novo mesto tabletes 4 30 4,15 5,78 5,41 4,06 2,71 A C02CA04 05-0042-01 Kamiren XL 4mg KRKA d.d., Novo mesto ilgstošas darbības tabletes 4 30 4,15 5,78 5,41 4,06 2,71 A C02CA04 09-0179-02 Doxonex SR 4mg Pharmaceutical Works "Polpharma" S.A. ilgstošas darbības tabletes 4 30 4,57 6,33 5,41 4,06 2,71 A C02CA04 02-0173-03 Cardura 4mg Pfizer Limited tabletes 4 30 5,55 7,59 5,41 4,06 2,71 A C02CA04 03-0053-02 Magurol 4mg Medochemie Ltd. tabletes 4 30 5,55 7,59 5,41 4,06 2,71 A C02CA04 00-0269-01 Cardura XL 4mg Pfizer Limited ilgstošas darbības tabletes 4 30 5,56 7,60 5,41 4,06 2,71 A C02CA04 01-0097-01 Zoxon 4mg Zentiva k.s. tabletes 4 30 6,96 9,41 5,41 4,06 2,71 A Doxorubicinum L01DB01 10-0185-01 Doxorubicin Actavis 10mg Actavis Group PCT ehf pulveris injekciju šķīduma pagatavošanai 10 1 2,44 3,45 3,44 2,58 1,72 A L01DB01 10-0186-01 Doxorubicin Actavis 50mg Actavis Group PCT ehf pulveris injekciju šķīduma pagatavošanai 50 1 9,68 12,91 12,91 9,68 6,46 A R L01DB01 99-0774-01 Doxorubicin-Teva 50mg Teva Pharma B.V. pulveris injekciju šķīduma pagatavošanai 50 1 10,81 14,32 12,91 9,68 6,46 A L01DB01 04-0120-01 Adriblastina PFS 50mg/25ml Pfizer Italia s.r.l. šķīdums injekcijām 50mg/ 25ml 1 14,19 18,49 12,91 9,68 6,46 A L01DB01 95-0067-01 Doxorubicin Ebewe 2mg/ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 50mg/ 25ml 1 14,19 18,49 12,91 9,68 6,46 A Enalaprilum C09AA02 00-0452-01 EnaHexal 20mg Hexal AG tabletes 20 30 2,06 2,93 2,93 2,20 1,47 A R C09AA02 09-0194-02 Enalapril Vitabalans 20mg Vitabalans Oy tabletes 20 30 2,17 3,08 2,93 2,20 1,47 A C09AA02 96-0145-02 Ednyt 20mg Gedeon Richter Plc. tabletes 20 30 2,22 3,15 2,93 2,20 1,47 A C09AA02 99-0080-02 Enarenal 20mg Pharmaceutical Works "Polpharma" S.A. tabletes 20 30 2,23 3,17 2,93 2,20 1,47 A C09AA02 01-0462-01 Berlipril 20mg Berlin-Chemie AG (Menarini Group) tabletes 20 30 2,28 3,24 2,93 2,20 1,47 A C09AA02 93-0520-02 Enap 20mg KRKA d.d., Novo mesto tabletes 20 60 4,95 6,82 5,76 4,32 2,88 A Epirubicinum L01DB03 07-0398-01 Epirubicin Actavis 2mg/ml Actavis Group hf šķīdums injekcijām 10mg/ 5ml 1 6,17 8,40 8,40 6,30 4,20 A R L01DB03 02-0303-01 Epirubicin "Ebewe" 2mg/ml Ebewe Pharma GmbH koncentrāts infūziju šķīduma pagatavošanai 10mg/ 5ml 1 6,56 8,89 8,40 6,30 4,20 A L01DB03 04-0057-01 Farmorubicin PFS 10mg/5ml Pfizer Italia s.r.l. šķīdums injekcijām 10mg/ 5ml 1 6,56 8,89 8,40 6,30 4,20 A L01DB03 99-0122-01 Farmorubicin RD 10mg Pfizer Italia s.r.l. pulveris injekciju šķīduma pagatavošanai 10 1 6,56 8,89 8,40 6,30 4,20 A L01DB03 07-0398-03 Epirubicin Actavis 2mg/ml Actavis Group hf šķīdums injekcijām 50mg/ 25ml 1 30,81 38,19 38,19 28,64 19,10 A R L01DB03 02-0303-03 Epirubicin "Ebewe" 2mg/ml Ebewe Pharma GmbH koncentrāts infūziju šķīduma pagatavošanai 50mg/ 25ml 1 33,10 40,89 38,19 28,64 19,10 A L01DB03 04-0056-01 Farmorubicin PFS 50mg/25ml Pfizer Italia s.r.l. šķīdums injekcijām 50mg/ 25ml 1 33,10 40,89 38,19 28,64 19,10 A L01DB03 99-0123-01 Farmorubicin RD 50mg Pfizer Italia s.r.l. pulveris injekciju šķīduma pagatavošanai 50 1 33,10 40,89 38,19 28,64 19,10 A Eprosartanum C09CA02 01-0436-02 Teveten 600mg Abbott Healthcare Products B.V. apvalkotas tabletes 600 28 13,50 17,64 2,55 1,91 1,28 A Escitalopramum N06AB10 07-0297-03 Cipralex 5mg H. Lundbeck A/S apvalkotas tabletes 5 28 6,33 8,60 1,89 1,42 0,95 A N06AB10 09-0497-03 Escitalopram Actavis 10mg Actavis Group PCT ehf apvalkotas tabletes 10 28 2,68 3,77 3,77 2,83 1,89 A R N06AB10 09-0171-04 Escitalopram-Teva 10mg Teva Pharma B.V. apvalkotas tabletes 10 28 2,78 3,91 3,77 2,83 1,89 A N06AB10 10-0182-03 Norestal 10mg Norameda UAB apvalkotas tabletes 10 28 3,52 4,95 3,77 2,83 1,89 A N06AB10 09-0377-02 Elicea 10mg KRKA d.d., Novo mesto apvalkotas tabletes 10 28 3,79 5,30 3,77 2,83 1,89 A N06AB10 11-0119-06 Escitalopram Orion 10mg Orion Corporation apvalkotas tabletes 10 28 4,02 5,60 3,77 2,83 1,89 A N06AB10 09-0417-06 Escitil 10mg Egis Pharmaceuticals PLC apvalkotas tabletes 10 28 4,02 5,60 3,77 2,83 1,89 A N06AB10 09-0263-02 Nepanil 10mg Gedeon Richter Plc. apvalkotas tabletes 10 28 5,17 7,11 3,77 2,83 1,89 A N06AB10 07-0298-03 Cipralex 10mg H. Lundbeck A/S apvalkotas tabletes 10 28 11,44 15,10 3,77 2,83 1,89 A N06AB10 11-0120-06 Escitalopram Orion 15mg Orion Corporation apvalkotas tabletes 15 28 6,14 8,36 5,63 4,22 2,82 A N06AB10 07-0299-03 Cipralex 15mg H. Lundbeck A/S apvalkotas tabletes 15 28 16,70 21,53 5,63 4,22 2,82 A N06AB10 09-0173-04 Escitalopram-Teva 20mg Teva Pharma B.V. apvalkotas tabletes 20 28 6,55 8,88 7,45 5,59 3,73 A N06AB10 10-0184-03 Norestal 20mg Norameda UAB apvalkotas tabletes 20 28 7,39 9,97 7,45 5,59 3,73 A N06AB10 09-0378-02 Elicea 20mg KRKA d.d., Novo mesto apvalkotas tabletes 20 28 7,79 10,48 7,45 5,59 3,73 A N06AB10 11-0121-06 Escitalopram Orion 20mg Orion Corporation apvalkotas tabletes 20 28 8,26 11,09 7,45 5,59 3,73 A N06AB10 09-0419-06 Escitil 20mg Egis Pharmaceuticals PLC apvalkotas tabletes 20 28 8,26 11,09 7,45 5,59 3,73 A Exemestanum L02BG06 10-0238-03 Exemestane Teva 25mg Teva Pharma B.V. apvalkotas tabletes 25 30 26,00 32,54 32,54 24,41 16,27 A R L02BG06 11-0045-01 Exemestane SanoSwiss 25mg SanoSwiss UAB apvalkotas tabletes 25 30 30,19 37,46 32,54 24,41 16,27 A L02BG06 02-0063-03 Aromasin 25mg Pfizer Italia s.r.l. apvalkotas tabletes 25 30 39,83 48,80 32,54 24,41 16,27 A Ezetimibum/ Simvastatinum C10BA02 06-0227-02 Inegy 10mg/20mg MSD-SP Limited tabletes 10/20 28 29,88 37,09 14,98 11,24 7,49 A C10BA02 06-0228-02 Inegy 10mg/40mg MSD-SP Limited tabletes 10/40 28 34,38 42,39 15,88 11,91 7,94 A Felodipinum C08CA02 01-0388-01 Presid 5mg TEVA Czech Industries s.r.o. ilgstošas darbības tabletes 5 30 3,47 4,88 4,42 3,32 2,21 A C08CA02 98-0305-01 Plendil 5mg AstraZeneca AB ilgstošas darbības tabletes 5 30 4,85 6,69 4,42 3,32 2,21 A C08CA02 01-0389-01 Presid 10mg TEVA Czech Industries s.r.o. ilgstošas darbības tabletes 10 30 6,58 8,93 8,76 6,57 4,38 A C08CA02 I000111-01 Plendil 10mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības tabletes 10 30 7,03 9,50 8,76 6,57 4,38 A P C08CA02 98-0304-01 Plendil 10mg AstraZeneca AB ilgstošas darbības tabletes 10 30 8,30 11,14 8,76 6,57 4,38 A Filgrastimum L03AA02 EU/1/08/445/001 Tevagrastim Teva Generics GmbH šķīdums injekcijām vai infūzijām 0.3mg/ 0.5ml 1 40,20 49,24 37,05 27,79 18,53 A L03AA02 05-0566-01 Neupogen 300mcg (0,6mg/ml) Amgen Europe B.V. šķīdums injekcijām pilnšļircē 0.3mg/ 0.5ml 1 44,34 54,11 37,05 27,79 18,53 A L03AA02 EU/1/08/495/003 Zarzio Sandoz GmbH šķīdums injekcijām vai infūzijām 0.3mg/ 0.5ml 5 161,13 185,23 185,23 138,92 92,62 A R L03AA02 EU/1/08/445/005 Tevagrastim Teva Generics GmbH šķīdums injekcijām vai infūzijām 0.48mg/ 0.8ml 1 64,29 76,76 57,28 42,96 28,64 A L03AA02 05-0567-01 Neupogen 480mcg (0,96mg/ml) Amgen Europe B.V. šķīdums injekcijām pilnšļircē 0.48mg/ 0.5ml 1 71,88 85,27 57,28 42,96 28,64 A L03AA02 EU/1/08/495/007 Zarzio Sandoz GmbH šķīdums injekcijām vai infūzijām 0.48mg/ 0.5ml 5 251,46 286,40 286,40 214,80 143,20 A R Finasteridum G04CB01 09-0454-03 Finasteride Portfarma 5mg Portfarma ehf apvalkotas tabletes 5 28 3,83 5,35 5,07 3,80 2,54 A G04CB01 08-0287-05 Finasteride Teva 5mg Teva Pharma B.V. apvalkotas tabletes 5 30 3,89 5,43 5,43 4,07 2,72 A R G04CB01 06-0270-01 Finasterid Actavis 5mg Actavis Group hf apvalkotas tabletes 5 30 4,33 6,01 5,43 4,07 2,72 A G04CB01 06-0254-05 Finster 5mg KRKA d.d., Novo mesto apvalkotas tabletes 5 30 4,63 6,41 5,43 4,07 2,72 A G04CB01 08-0063-07 Ulgafen 5mg Pharmaceutical Company Jelfa SA apvalkotas tabletes 5 30 5,56 7,60 5,43 4,07 2,72 A G04CB01 99-0984-04 Prostarinol 5mg Olainfarm A/S apvalkotas tabletes 5 30 5,99 8,16 5,43 4,07 2,72 A G04CB01 07-0101-06 Androfin 5mg G.L. Pharma GmbH apvalkotas tabletes 5 30 6,31 8,58 5,43 4,07 2,72 A G04CB01 04-0150-01 Penester 5mg Zentiva k.s. apvalkotas tabletes 5 30 7,35 9,91 5,43 4,07 2,72 A Gabapentinum N03AX12 08-0183-02 Gabapentin Actavis 300mg Actavis Group PCT ehf cietas kapsulas 300 50 5,51 7,55 7,55 5,66 3,78 A R N03AX12 01-0277-01 Neurontin 300mg Pfizer Limited cietas kapsulas 300 50 6,12 8,33 7,55 5,66 3,78 A N03AX12 03-0385-03 Gabagamma 300mg Worwag Pharma GmbH & Co.KG cietas kapsulas 300 50 7,52 10,14 7,55 5,66 3,78 A N03AX12 05-0418-01 Gabapentin Nycomed 300mg Nycomed Danmark ApS cietas kapsulas 300 50 7,52 10,14 7,55 5,66 3,78 A N03AX12 04-0104-01 Gordius 300mg Gedeon Richter Plc. cietas kapsulas 300 50 7,52 10,14 7,55 5,66 3,78 A N03AX12 01-0278-01 Neurontin 400mg Pfizer Limited cietas kapsulas 400 50 8,26 11,09 10,06 7,55 5,03 A N03AX12 05-0419-01 Gabapentin Nycomed 400mg Nycomed Danmark ApS cietas kapsulas 400 50 10,14 13,50 10,06 7,55 5,03 A N03AX12 04-0105-01 Gordius 400mg Gedeon Richter Plc. cietas kapsulas 400 50 10,14 13,50 10,06 7,55 5,03 A N03AX12 03-0386-03 Gabagamma 400mg Worwag Pharma GmbH & Co.KG cietas kapsulas 400 50 10,51 13,96 10,06 7,55 5,03 A Indapamidum C03BA11 09-0117-05 Indapamide Actavis 1,5mg Actavis Group PCT ehf ilgstošas darbības tabletes 1,5 30 1,96 2,80 2,80 2,10 1,40 A R C03BA11 10-0006-06 Indamax 1,5mg Teva Pharma B.V. ilgstošas darbības tabletes 1,5 30 2,40 3,39 2,80 2,10 1,40 A C03BA11 05-0457-02 Rawel SR 1,5mg KRKA d.d., Novo mesto ilgstošas darbības apvalkotas tabletes 1,5 30 2,41 3,40 2,80 2,10 1,40 A C03BA11 09-0057-01 Indapamide Orion 1,5mg Orion Corporation ilgstošas darbības tabletes 1,5 30 2,57 3,62 2,80 2,10 1,40 A C03BA11 08-0313-03 Indapen SR 1,5mg J&P Pharma UK.Ltd. ilgstošas darbības apvalkotas tabletes 1,5 30 2,57 3,62 2,80 2,10 1,40 A C03BA11 05-0157-01 Tertensif SR 1,5mg Les Laboratoires Servier ilgstošas darbības apvalkotas tabletes 1,5 30 3,41 4,80 2,80 2,10 1,40 A C03BA11 02-0233-01 Indatens 2,5mg Mepha Lda cietas kapsulas 2.5 30 1,17 1,69 1,36 1,02 0,68 A Irbesartanum C09CA04 EU/1/97/046/022 Aprovel Sanofi Pharma Bristol-Myers Squibb SCN apvalkotas tabletes 150 28 10,43 13,85 2,55 1,91 1,28 A C09CA04 EU/1/97/046/027 Aprovel Sanofi Pharma Bristol-Myers Squibb SCN apvalkotas tabletes 300 28 13,63 17,80 4,85 3,64 2,43 A Irinotecanum L01XX19 07-0305-01 Irinotecan Actavis 20mg/ml Actavis Group PCT ehf koncentrāts infūziju šķīduma pagatavošanai 40mg/ 2ml 1 11,50 15,18 15,18 11,39 7,59 A R L01XX19 10-0211-01 Irinotecan Ebewe 20mg/ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 40mg/ 2ml 1 12,74 16,70 15,18 11,39 7,59 A L01XX19 98-0823-01 Campto 40mg/2ml Pfizer Enterprises SARL koncentrāts infūziju šķīduma pagatavošanai 40mg/ 2ml 1 46,80 57,00 15,18 11,39 7,59 A L01XX19 07-0305-02 Irinotecan Actavis 20mg/ml Actavis Group hf koncentrāts infūziju šķīduma pagatavošanai 100mg/ 5ml 1 28,82 35,85 35,85 26,89 17,93 A R L01XX19 10-0212-01 Irinotecan Ebewe 20mg/ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 100mg/ 5ml 1 31,94 39,52 35,85 26,89 17,93 A L01XX19 98-0824-01 Campto 100mg/5ml Pfizer Enterprises SARL koncentrāts infūziju šķīduma pagatavošanai 100mg/ 5ml 1 85,19 100,17 35,85 26,89 17,93 A L01XX19 08-0168-01 Campto 300mg/15ml Pfizer Enterprises SARL koncentrāts infūziju šķīduma pagatavošanai 300mg/ 15ml 1 310,63 352,67 107,55 80,66 53,78 A Isosorbidi mononitratum C01DA14 07-0301-01 Isosorbide mononitrate Vitabalans 20mg Vitabalans Oy tabletes 20 30 0,92 1,34 1,27 0,95 0,64 A C01DA14 99-0429-02 Olicard 40mg Abbott Products GmbH ilgstošas darbības cietas kapsulas 40 50 5,58 7,64 4,75 3,56 2,38 A C01DA14 00-0229-01 Elantan long 50mg UCB Pharma GmbH ilgstošas darbības cietas kapsulas 50 20 3,01 4,28 2,35 1,76 1,18 A C01DA14 98-0409-01 Imdur 60mg AstraZeneca AB ilgstošas darbības tabletes 60 30 5,00 6,89 4,19 3,14 2,10 A C01DA14 99-0430-02 Olicard 60mg Abbott Products GmbH ilgstošas darbības cietas kapsulas 60 50 7,11 9,61 6,90 5,18 3,45 A C01DA14 03-0479-03 Isomonit 60mg Hexal AG ilgstošas darbības tabletes 60 60 6,41 8,70 8,28 6,21 4,14 A Lacidipinum C08CA09 99-0780-02 Lacipil 4mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 4 28 4,76 6,57 5,84 4,38 2,92 A C08CA09 99-0780-03 Lacipil 4mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 4 56 9,36 12,50 11,65 8,74 5,83 A C08CA09 I000157-01 Lacipil 6mg Scandic Pharma SIA (paralēlais importētājs) apvalkotas tabletes 6 28 7,16 9,67 8,74 6,56 4,37 A P C08CA09 03-0414-02 Lacipil 6mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 6 28 7,96 10,70 8,74 6,56 4,37 A C08CA09 03-0414-03 Lacipil 6mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 6 56 13,58 17,74 17,39 13,04 8,70 A Lamotriginum N03AX09 97-0588-07 Lamictal 25mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 25 28 1,47 2,12 1,39 1,04 0,70 A N03AX09 97-0589-05 Lamictal 50mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 50 28 2,99 4,19 2,50 1,88 1,25 A N03AX09 08-0375-08 Lamotrigine Ranbaxy 50mg Ranbaxy UK Ltd disperģējamas tabletes 50 30 1,87 2,68 2,68 2,01 1,34 A R N03AX09 97-0589-11 Lamictal 50mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 50 56 6,21 8,44 4,99 3,74 2,50 A N03AX09 97-0590-06 Lamictal 100mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 100 28 6,21 8,44 4,99 3,74 2,50 A N03AX09 08-0376-08 Lamotrigine Ranbaxy 100mg Ranbaxy UK Ltd disperģējamas tabletes 100 30 4,02 5,60 5,35 4,01 2,68 A N03AX09 97-0590-11 Lamictal 100mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 100 56 12,86 16,86 9,97 7,48 4,99 A N03AX09 97-0591-06 Lamictal 200mg GlaxoSmithKline Latvia SIA disperģējamas/ košļājamas tabletes 200 28 12,86 16,86 9,97 7,48 4,99 A Latanoprostum S01EE01 09-0227-01 Latanoprost Actavis 50mcg/ml Actavis Group PCT ehf acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 2,87 4,02 4,02 3,02 2,01 A R S01EE01 09-0121-01 Latanoprost-ratiopharm 50mcg/ml Ratiopharm GmbH acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 3,12 4,42 4,02 3,02 2,01 A S01EE01 09-0246-01 Xaloptic 0,005% Medana Pharma SA acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 3,52 4,95 4,02 3,02 2,01 A S01EE01 09-0393-01 UNILAT 50mcg/ml Unimed Pharma Ltd. acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 5,97 8,14 4,02 3,02 2,01 A S01EE01 00-0502-01 Xalatan 50mcg/ml Pfizer Europe MA EEIG acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 6,83 9,24 4,02 3,02 2,01 A S01EE01 11-0109-01 Latizolil 50mcg/ml Sandoz d.d. acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 3,34 4,72 4,02 3,02 2,01 A S01EE01 10-0502-01 Latalux 50mcg/ml Sanitas AB acu pilieni, šķīdums 0.05mg/ ml-2.5ml 1 gab. 3,81 5,33 4,02 3,02 2,01 A S01EE01 09-0393-02 UNILAT 50mcg/ml Unimed Pharma Ltd. acu pilieni, šķīdums 0.05mg/ ml-2.5ml 3 gab. 16,60 21,40 12,01 9,01 6,01 A S01EE01 00-0502-02 Xalatan 50mcg/ml Pfizer Europe MA EEIG acu pilieni, šķīdums 0.05mg/ ml-2.5ml 3 gab. 20,10 25,60 12,01 9,01 6,01 A Latanoprostum/ Timololum S01ED51 11-0123-01 Latanoprost/Timolol Actavis 50mcg/5ml/ml Actavis Group PCT ehf acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 4,21 5,86 5,12 3,84 2,56 A S01ED51 11-0262-01 Latira 50mcg/5mg/ml Ratiopharm GmbH acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 4,31 5,98 5,12 3,84 2,56 A S01ED51 11-0403-01 Timlatan 50mcg/5mg/ml Sanitas AB acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 5,09 7,00 5,12 3,84 2,56 A S01ED51 11-0214-01 Latoxap 50mcg/5mg/ml Sandoz d.d. acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 5,12 7,04 5,12 3,84 2,56 A S01ED51 11-0116-01 Xalopticom 50mcg/5mg/ml Pharmaceutical Works "Polpharma" S.A. acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 6,35 8,62 5,12 3,84 2,56 A S01ED51 03-0418-01 Xalacom Pfizer Europe MA EEIG acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 1 gab. 7,46 10,06 5,12 3,84 2,56 A S01ED51 03-0418-02 Xalacom Pfizer Europe MA EEIG acu pilieni, šķīdums 0.05/5mg/ ml-2.5ml 3 gab. 21,84 27,64 15,29 11,47 7,65 A Leflunomidum L04AA13 EU/1/99/118/003 Arava Sanofi-Aventis Deutschland GmbH apvalkotas tabletes 10 30 15,68 20,31 17,07 12,80 8,54 A Lercanidipinum C08CA13 09-0290-03 Lercanidipine Actavis 10mg Actavis Group PCT ehf apvalkotas tabletes 10 28 1,92 2,74 2,74 2,06 1,37 A R C08CA13 10-0066-05 Lercanidipine-ratiopharm 10mg Ratiopharm GmbH apvalkotas tabletes 10 28 3,80 5,32 2,74 2,06 1,37 A C08CA13 10-0158-02 Ledipin 10mg Teva Pharma B.V. apvalkotas tabletes 10 28 4,03 5,62 2,74 2,06 1,37 A C08CA13 10-0647-03 Lercanidipin Orion 10mg Orion Corporation apvalkotas tabletes 10 28 4,29 5,96 2,74 2,06 1,37 A C08CA13 01-0392-03 Lercapin 10mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 10 28 7,90 10,63 2,74 2,06 1,37 A C08CA13 01-0392-08 Lercapin 10mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 10 90 7,11 9,61 8,73 6,55 4,37 A C08CA13 10-0648-03 Lercanidipin Orion 20mg Orion Corporation apvalkotas tabletes 20 28 8,35 11,20 4,59 3,44 2,30 A C08CA13 05-0296-12 Lercapin 20mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 20 90 13,41 17,53 14,58 10,94 7,29 A Letrozolum L02BG04 10-0160-07 Letrozole Teva 2,5mg Teva Pharma B.V. apvalkotas tabletes 2,5 30 31,00 38,42 38,42 28,82 19,21 A R L02BG04 09-0021-03 Letrozole SanoSwiss 2,5mg SanoSwiss UAB apvalkotas tabletes 2,5 30 32,41 40,07 38,42 28,82 19,21 A L02BG04 98-0087-01 Femara 2,5mg Novartis Finland Oy apvalkotas tabletes 2,5 30 46,05 56,11 38,42 28,82 19,21 A Lisinoprilum/ Amlodipinum C09BB03 09-0036-01 Dironorm 10mg/5mg Gedeon Richter Plc. tabletes 10/5 30 4,07 5,67 4,23 3,17 2,12 A C09BB03 09-0465-01 Dironorm 20mg/10mg Gedeon Richter Plc. tabletes 20/10 30 6,72 9,11 7,83 5,87 3,92 A Losartanum C09CA01 09-0438-03 Lorista 50mg KRKA d.d., Novo mesto apvalkotas tabletes 50 28 1,88 2,69 2,55 1,91 1,28 A C09CA01 96-0155-01 Cozaar 50mg SIA "Merck Sharp & Dohme Latvija" apvalkotas tabletes 50 28 8,21 11,02 2,55 1,91 1,28 A C09CA01 07-0142-14 Losartan Actavis 50mg Actavis Group hf apvalkotas tabletes 50 30 1,91 2,73 2,73 2,05 1,37 A R C09CA01 06-0092-04 Lozap 50mg Zentiva a.s. apvalkotas tabletes 50 30 2,28 3,24 2,73 2,05 1,37 A C09CA01 09-0439-05 Lorista 100mg KRKA d.d., Novo mesto apvalkotas tabletes 100 28 3,83 5,35 4,85 3,64 2,43 A C09CA01 04-0343-01 Cozaar 100mg SIA "Merck Sharp & Dohme Latvija" apvalkotas tabletes 100 28 10,43 13,85 4,85 3,64 2,43 A C09CA01 07-0143-14 Losartan Actavis 100mg Actavis Group hf apvalkotas tabletes 100 30 3,71 5,20 5,20 3,90 2,60 A R C09CA01 06-0093-04 Lozap 100mg Zentiva a.s. apvalkotas tabletes 100 30 4,67 6,45 5,20 3,90 2,60 A Metoprololum C07AB02 99-0223-01 Metoprolol-ratiopharm 50mg Ratiopharm GmbH tabletes 50 30 0,61 0,88 0,88 0,66 0,44 A R C07AB02 09-0167-04 Metoprolol Polpharma 47,5mg Pharmaceutical Works "Polpharma" S.A. ilgstošas darbības tabletes 50* 28 1,48 2,13 2,13 1,60 1,07 A R C07AB02 96-0574-02 Metoprolol Meda 50mg Meda Pharma SIA tabletes 50 30 0,65 0,95 0,88 0,66 0,44 A C07AB02 01-0227-01 Emzok 50mg TEVA Czech Industries s.r.o. ilgstošas darbības tabletes 50 30 1,67 2,40 2,28 1,71 1,14 A C07AB02 07-0313-03 Metoprolol-ratiopharm retard 50mg Ratiopharm GmbH ilgstošas darbības tabletes 50 30 1,77 2,53 2,28 1,71 1,14 A C07AB02 05-0090-04 Metoprolol HEXAL Z 47,5mg Hexal AG ilgstošas darbības tabletes 50* 30 1,97 2,81 2,28 1,71 1,14 A C07AB02 I000269-01 Betaloc ZOK 50mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības tabletes 50 30 2,76 3,88 2,28 1,71 1,14 A P C07AB02 I000231-01 Betaloc ZOK 50mg Scandic Pharma SIA (paralēlais importētājs) ilgstošas darbības tabletes 50 30 2,92 4,09 2,28 1,71 1,14 A P C07AB02 98-0300-01 Betaloc ZOK 50mg AstraZeneca AB ilgstošas darbības tabletes 50 30 3,25 4,59 2,28 1,71 1,14 A C07AB02 96-0082-01 Corvitol 50mg Berlin-Chemie AG/ Menarini Group tabletes 50 50 1,33 1,92 1,45 1,09 0,73 A C07AB02 09-0168-04 Metoprolol Polpharma 95mg Pharmaceutical Works "Polpharma" S.A. ilgstošas darbības tabletes 100* 28 2,19 3,11 3,11 2,33 1,56 A R C07AB02 99-0224-01 Metoprolol-ratiopharm 100mg Ratiopharm GmbH tabletes 100 30 1,52 2,18 1,74 1,31 0,87 A C07AB02 01-0228-01 Emzok 100mg TEVA Czech Industries s.r.o. ilgstošas darbības tabletes 100 30 2,51 3,54 3,33 2,50 1,67 A C07AB02 07-0314-03 Metoprolol-ratiopharm retard 100mg Ratiopharm GmbH ilgstošas darbības tabletes 100 30 2,99 4,19 3,33 2,50 1,67 A C07AB02 05-0091-04 Metoprolol HEXAL Z 95mg Hexal AG ilgstošas darbības tabletes 100* 30 3,02 4,29 3,33 2,50 1,67 A C07AB02 I000270-01 Betaloc ZOK 100mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības tabletes 100 30 4,03 5,62 3,33 2,50 1,67 A P C07AB02 I000229-01 Betaloc ZOK 100mg Scandic Pharma SIA (paralēlais importētājs) ilgstošas darbības tabletes 100 30 4,61 6,37 3,33 2,50 1,67 A P C07AB02 98-0301-01 Betaloc ZOK 100mg AstraZeneca AB ilgstošas darbības tabletes 100 30 5,13 7,06 3,33 2,50 1,67 A C07AB02 05-0092-04 Metoprolol HEXAL Z 142,5mg Hexal AG ilgstošas darbības tabletes 150* 30 4,48 6,20 4,98 3,74 2,49 A C07AB02 07-0315-03 Metoprolol-ratiopharm retard 200mg Ratiopharm GmbH ilgstošas darbības tabletes 200 30 5,34 7,32 6,60 4,95 3,30 A Moxonidinum C02AC05 07-0043-04 Moxonidin Actavis 0,4mg Actavis Group hf apvalkotas tabletes 0.4 30 3,95 5,51 5,51 4,13 2,76 A R C02AC05 04-0123-01 MoxonidinHexal 0,4mg Hexal AG apvalkotas tabletes 0.4 30 5,11 7,03 5,51 4,13 2,76 A C02AC05 05-0016-01 Moxogamma 0,4mg Worwag Pharma GmbH & Co.KG apvalkotas tabletes 0.4 30 5,94 8,10 5,51 4,13 2,76 A C02AC05 00-0564-01 Physiotens 0,4mg Abbott Products GmbH apvalkotas tabletes 0.4 28 6,58 8,93 5,14 3,86 2,57 A Natrii alendronatum/ Cholecalci-ferolum M05BB03 EU/1/05/310/002 Fosavance Merck Sharp & Dohme Ltd. tabletes 70/0.07 4 10,76 14,27 6,05 4,54 3,03 A M05BB03 EU/1/05/310/007 Fosavance Merck Sharp & Dohme Ltd. tabletes 70/0.14 4 10,22 13,60 6,22 4,67 3,11 A M05BB03 EU/1/05/310/008 Fosavance Merck Sharp & Dohme Ltd. tabletes 70/0.14 12 27,36 34,14 18,56 13,92 9,28 A Natrii risedronatum M05BA07 08-0339-03 Risonate 35mg Teva Pharma B.V. apvalkotas tabletes 35 4 4,24 5,89 5,89 4,42 2,95 A R M05BA07 08-0309-03 Risedronate Sodium Actavis 35mg Actavis Group PCT ehf apvalkotas tabletes 35 4 4,51 6,25 5,89 4,42 2,95 A M05BA07 10-0479-03 Risedronate sodium Portfarma 35mg Portfarma ehf apvalkotas tabletes 35 4 4,58 6,34 5,89 4,42 2,95 A M05BA07 07-0271-02 Risendros 35mg Zentiva k.s. apvalkotas tabletes 35 4 4,82 6,65 5,89 4,42 2,95 A M05BA07 I000254-01 Risendros 35mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 35 4 4,98 6,87 5,89 4,42 2,95 A P M05BA07 08-0308-03 Norifaz 35mg Zaklad Farmaceutyczny Adamed Pharma S.A. apvalkotas tabletes 35 4 5,07 6,98 5,89 4,42 2,95 A M05BA07 09-0049-01 Ribidron 35mg Ratiopharm GmbH apvalkotas tabletes 35 4 6,49 8,80 5,89 4,42 2,95 A M05BA07 07-0271-04 Risendros 35mg Zentiva k.s. apvalkotas tabletes 35 12 14,77 19,21 16,65 12,49 8,33 A Nebivololum C07AB12 08-0138-07 Nebivolol Actavis 5mg Actavis Group PCT ehf tabletes 5 90 5,61 7,67 7,67 5,75 3,84 A R C07AB12 98-0344-08 Nebilet 5mg Menarini International Operations Luxembourg S.A. tabletes 5 90 9,48 12,66 7,67 5,75 3,84 A Olanzapinum N05AH03 EU/1/07/415/033 Zalasta KRKA d.d., Novo mesto mutē disperģējamas tabletes 5 28 3,86 5,40 5,40 4,05 2,70 A R N05AH03 EU/1/07/427/023 Olanzapine Teva Teva Pharma B.V. mutē disperģējamas tabletes 5 28 4,21 5,86 5,40 4,05 2,70 A N05AH03 08-0244-05 Olanzapine Actavis 5mg Actavis Group PCT ehf mutē disperģējamas tabletes 5 28 4,29 5,96 5,40 4,05 2,70 A N05AH03 10-0311-02 Olanzapine Orion 5mg Orion Corporation mutē disperģējamas tabletes 5 28 4,82 6,65 5,40 4,05 2,70 A N05AH03 11-0240-01 Zolafren 5mg Laboratorios Adamed Sp.z o.o. tabletes 5 28 5,96 8,12 5,40 4,05 2,70 A N05AH03 11-0236-01 Zolaswift 5mg Zaklad Farmaceutyczny Adamed Pharma S.A. mutē disperģējamas tabletes 5 28 6,03 8,21 5,40 4,05 2,70 A N05AH03 09-0390-02 Lapozan 5mg Medochemie Ltd. mutē disperģējamas tabletes 5 30 4,39 6,09 5,79 4,34 2,90 A N05AH03 EU/1/07/415/043 Zalasta KRKA d.d., Novo mesto mutē disperģējamas tabletes 10 28 7,38 9,96 9,96 7,47 4,98 A R N05AH03 EU/1/07/427/027 Olanzapine Teva Teva Pharma B.V. mutē disperģējamas tabletes 10 28 8,01 10,76 9,96 7,47 4,98 A N05AH03 08-0245-05 Olanzapine Actavis 10mg Actavis Group PCT ehf mutē disperģējamas tabletes 10 28 8,35 11,20 9,96 7,47 4,98 A N05AH03 10-0312-02 Olanzapine Orion 10mg Orion Corporation mutē disperģējamas tabletes 10 28 9,22 12,32 9,96 7,47 4,98 A N05AH03 07-0281-04 Olanzapin-ratiopharm 10mg Ratiopharm GmbH tabletes 10 28 11,69 15,41 9,96 7,47 4,98 A N05AH03 11-0241-01 Zolafren 10mg Laboratorios Adamed Sp.z o.o. tabletes 10 28 12,16 15,99 9,96 7,47 4,98 A N05AH03 11-0237-01 Zolaswift 10mg Zaklad Farmaceutyczny Adamed Pharma S.A. mutē disperģējamas tabletes 10 28 12,40 16,28 9,96 7,47 4,98 A N05AH03 09-0391-02 Lapozan 10mg Medochemie Ltd. mutē disperģējamas tabletes 10 30 8,45 11,33 10,67 8,00 5,34 A N05AH03 EU/1/07/415/048 Zalasta KRKA d.d., Novo mesto mutē disperģējamas tabletes 15 28 11,06 14,64 14,64 10,98 7,32 A R N05AH03 10-0313-02 Olanzapine Orion 15mg Orion Corporation mutē disperģējamas tabletes 15 28 14,19 18,49 14,64 10,98 7,32 A Olmesartanum C09CA08 09-0440-02 Olimestra 10mg KRKA d.d., Novo mesto apvalkotas tabletes 10 28 2,20 3,12 1,27 0,95 0,64 A C09CA08 04-0062-01 Mesar 10mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 10 28 11,12 14,71 1,27 0,95 0,64 A C09CA08 09-0441-02 Olimestra 20mg KRKA d.d., Novo mesto apvalkotas tabletes 20 28 4,32 5,99 2,55 1,91 1,28 A C09CA08 04-0063-01 Mesar 20mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 20 28 13,28 17,37 2,55 1,91 1,28 A C09CA08 09-0442-02 Olimestra 40mg KRKA d.d., Novo mesto apvalkotas tabletes 40 28 6,02 8,20 4,85 3,64 2,43 A C09CA08 04-0064-01 Mesar 40mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 40 28 16,23 20,97 4,85 3,64 2,43 A Olmesartanum/ Amlodipinum C09DB02 08-0270-02 Sanoral 20mg/5mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 20/5 28 13,32 17,42 3,86 2,90 1,93 A C09DB02 08-0271-02 Sanoral 40mg/5mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 40/5 28 13,85 18,08 6,16 4,62 3,08 A C09DB02 08-0272-02 Sanoral 40mg/10mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 40/10 28 13,85 18,08 6,94 5,21 3,47 A Olmesartanum/ Hydrochloro-thiazidum C09DA08 05-0632-02 Mesar Plus 20/25mg Menarini International Operations Luxembourg S.A. apvalkotas tabletes 20/25 28 13,28 17,37 5,35 4,01 2,68 A Omeprazolum A02BC01 00-0761-03 Omeprazol Stirol 20mg StirolBiofarm Baltikum SIA cietas kapsulas 20 30 2,07 2,95 2,95 2,21 1,48 A R A02BC01 00-0797-02 Omeprazole-ratiopharm 20mg Ratiopharm GmbH zarnās šķīstošas cietas kapsulas 20 30 2,20 3,12 2,95 2,21 1,48 A A02BC01 96-0146-04 Gasec Gastrocaps 20mg Mepha Lda. zarnās šķīstošas cietas kapsulas 20 56 4,59 6,35 5,43 4,07 2,72 A Oxaliplatinum L01XA03 07-0396-01 Oxaliplatin Actavis 5mg/ml Actavis Group hf pulveris infūziju šķīduma pagatavošanai 50 1 11,83 15,58 15,58 11,69 7,79 A R L01XA03 07-0292-01 Oxaliplatin-Teva 5mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 50mg/ 10ml 1 12,00 15,79 15,58 11,69 7,79 A L01XA03 07-0396-02 Oxaliplatin Actavis 5mg/ml Actavis Group hf pulveris infūziju šķīduma pagatavošanai 100 1 21,18 26,87 26,87 20,15 13,44 A R L01XA03 07-0292-02 Oxaliplatin-Teva 5mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 100mg/ 20ml 1 24,00 30,18 26,87 20,15 13,44 A Paclitaxelum L01CD01 08-0080-01 Paclitaxel Actavis 6mg/ml Actavis Group hf koncentrāts infūziju šķīduma pagatavošanai 30mg/ 5ml 1 8,94 11,96 11,96 8,97 5,98 A R L01CD01 05-0316-01 Paclitaxel-Teva 6mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 30mg/ 5ml 1 9,00 12,04 11,96 8,97 5,98 A L01CD01 08-0294-01 Paclitaxel SanoSwiss 6mg/ml SanoSwiss UAB koncentrāts infūziju šķīduma pagatavošanai 30mg/ 5ml 1 9,57 12,78 11,96 8,97 5,98 A L01CD01 03-0395-01 Paclitaxel "Ebewe" 30mg/5ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 30mg/ 5ml 1 16,91 21,77 11,96 8,97 5,98 A L01CD01 08-0080-02 Paclitaxel Actavis 6mg/ml Actavis Group PCT ehf koncentrāts infūziju šķīduma pagatavošanai 100mg/ 16.7ml 1 42,39 51,81 39,87 29,90 19,94 A L01CD01 05-0316-02 Paclitaxel-Teva 6mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 100mg/ 16.7ml 1 57,01 68,61 39,87 29,90 19,94 A L01CD01 08-0080-04 Paclitaxel Actavis 6mg/ml Actavis Group PCT ehf koncentrāts infūziju šķīduma pagatavošanai 300mg/ 50ml 1 87,71 103,00 103,00 77,25 51,50 A R L01CD01 05-0316-03 Paclitaxel-Teva 6mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 300mg/ 50ml 1 96,00 112,28 103,00 77,25 51,50 A L01CD01 08-0297-01 Paclitaxel SanoSwiss 6mg/ml SanoSwiss UAB koncentrāts infūziju šķīduma pagatavošanai 300mg/ 50ml 1 104,30 121,58 103,00 77,25 51,50 A L01CD01 03-0399-01 Paclitaxel "Ebewe" 300mg/50ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 300mg/ 50ml 1 155,96 179,44 103,00 77,25 51,50 A Paroxetinum N06AB05 05-0459-01 Paroxetin Actavis 20mg Actavis Group PCT ehf apvalkotas tabletes 20 30 3,75 5,25 5,25 3,94 2,63 A R N06AB05 02-0441-01 Rexetin 20mg Gedeon Richter Plc. apvalkotas tabletes 20 30 5,00 6,89 5,25 3,94 2,63 A N06AB05 07-0065-04 Arketis 20mg Medochemie Ltd. tabletes 20 30 5,02 6,91 5,25 3,94 2,63 A N06AB05 09-0370-07 Paroxetin Hexal 20mg Hexal AG apvalkotas tabletes 20 30 5,15 7,08 5,25 3,94 2,63 A N06AB05 09-0525-02 Paroxetine Orion 20mg Orion Corporation apvalkotas tabletes 20 30 5,99 8,16 5,25 3,94 2,63 A N06AB05 I000152-01 Seroxat 20mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 20 30 10,09 13,44 5,25 3,94 2,63 A P N06AB05 99-1041-03 Seroxat 20mg GlaxoSmithKline Latvia SIA apvalkotas tabletes 20 30 11,64 15,34 5,25 3,94 2,63 A N06AB05 07-0065-06 Arketis 20mg Medochemie Ltd. tabletes 20 60 7,48 10,08 10,08 7,56 5,04 A R Perindoprilum C09AA04 11-0184-01 Pricoron 4mg Zentiva k.s. tabletes 4 30 1,46 2,11 2,11 1,58 1,06 A R C09AA04 08-0128-02 Perindobax 4mg Ranbaxy UK Ltd tabletes 4 30 1,50 2,16 2,11 1,58 1,06 A C09AA04 10-0262-02 Perindopril Pfizer 4mg Pfizer Europe MA EEIG tabletes 4 30 2,18 3,10 2,11 1,58 1,06 A C09AA04 08-0289-01 Stopress 4mg Pharmaceutical Works "Polpharma" S.A. tabletes 4 30 2,34 3,32 2,11 1,58 1,06 A C09AA04 08-0359-07 Perindalon 4mg Sandoz d.d. tabletes 4 30 2,60 3,66 2,11 1,58 1,06 A C09AA04 06-0128-01 Prenessa 4mg Krka Polska Sp.z o.o. tabletes 4 30 2,68 3,77 2,11 1,58 1,06 A C09AA04 08-0320-01 Vidotin 4mg Gedeon Richter Plc. tabletes 4 30 2,68 3,77 2,11 1,58 1,06 A C09AA04 05-0263-01 Prestarium 5mg Les Laboratoires Servier apvalkotas tabletes 5 30 4,48 6,20 2,11 1,58 1,06 A C09AA04 10-0269-05 Prestarium 5mg Les Laboratoires Servier mutē disperģējamas tabletes 5 30 4,14 5,76 2,52 1,89 1,26 A C09AA04 05-0263-08 Prestarium 5mg Les Laboratoires Servier apvalkotas tabletes 5 90 11,32 14,95 6,21 4,66 3,11 A C09AA04 11-0185-01 Pricoron 8mg Zentiva k.s. tabletes 8 30 2,72 3,82 3,82 2,87 1,91 A R C09AA04 08-0322-01 Perindobax 8mg Ranbaxy UK Ltd tabletes 8 30 2,83 3,98 3,82 2,87 1,91 A C09AA04 08-0290-01 Stopress 8mg Pharmaceutical Works "Polpharma" S.A. tabletes 8 30 4,10 5,71 3,82 2,87 1,91 A C09AA04 09-0258-06 Perindalon 8mg Sandoz d.d. tabletes 8 30 4,52 6,26 3,82 2,87 1,91 A C09AA04 08-0288-04 Prenessa 8mg Krka Polska Sp.z o.o. tabletes 8 30 4,66 6,44 3,82 2,87 1,91 A C09AA04 08-0321-01 Vidotin 8mg Gedeon Richter Plc. tabletes 8 30 4,66 6,44 3,82 2,87 1,91 A C09AA04 10-0270-05 Prestarium 10mg Les Laboratoires Servier mutē disperģējamas tabletes 10 30 6,55 8,88 4,62 3,47 2,31 A C09AA04 05-0264-01 Prestarium 10mg Les Laboratoires Servier apvalkotas tabletes 10 30 6,70 9,08 3,82 2,87 1,91 A C09AA04 05-0264-08 Prestarium 10mg Les Laboratoires Servier apvalkotas tabletes 10 90 18,05 23,14 11,34 8,51 5,67 A Perindoprilum/ Amlodipinum C09BB04 11-0360-07 Amlessa 4mg/5mg KRKA d.d., Novo mesto tabletes 4/5 30 2,47 3,48 3,48 2,61 1,74 A R C09BB04 11-0359-07 Amlessa 4mg/10mg KRKA d.d., Novo mesto tabletes 4/10 30 3,09 4,39 4,35 3,26 2,18 A C09BB04 08-0111-07 Presteram 5mg/5mg Les Laboratoires Servier tabletes 5/5 30 5,36 7,35 3,48 2,61 1,74 A C09BB04 08-0111-11 Presteram 5mg/5mg Les Laboratoires Servier tabletes 5/5 90 14,78 19,22 10,35 7,76 5,18 A C09BB04 08-0112-07 Presteram 5mg/10mg Les Laboratoires Servier tabletes 5/10 30 5,79 7,91 4,35 3,26 2,18 A C09BB04 08-0112-11 Presteram 5mg/10mg Les Laboratoires Servier tabletes 5/10 90 16,55 21,35 12,96 9,72 6,48 A C09BB04 11-0362-07 Amlessa 8mg/5mg KRKA d.d., Novo mesto tabletes 8/5 30 3,75 5,25 5,22 3,92 2,61 A C09BB04 11-0361-07 Amlessa 8mg/10mg KRKA d.d., Novo mesto tabletes 8/10 30 4,36 6,05 6,05 4,54 3,03 A R C09BB04 08-0113-07 Presteram 10mg/5mg Les Laboratoires Servier tabletes 10/5 30 7,38 9,96 5,22 3,92 2,61 A C09BB04 08-0113-11 Presteram 10mg/5mg Les Laboratoires Servier tabletes 10/5 90 21,06 26,72 15,57 11,68 7,79 A C09BB04 08-0114-07 Presteram 10mg/10mg Les Laboratoires Servier tabletes 10/10 30 8,21 11,02 6,05 4,54 3,03 A C09BB04 08-0114-11 Presteram 10mg/10mg Les Laboratoires Servier tabletes 10/10 90 23,43 29,51 18,09 13,57 9,05 A Perindoprilum/ Indapamidum C09BA04 11-0426-02 Pricoron Duo 2mg/0,625mg Zentiva k.s. tabletes 2/0.625 30 2,79 3,92 2,22 1,67 1,11 A C09BA04 09-0083-04 Perindap 2mg/0,625mg Ratiopharm GmbH tabletes 2/0.625 30 3,32 4,68 2,22 1,67 1,11 A C09BA04 07-0369-04 Prenewel 2mg/0,625mg Krka Polska Sp.z o.o. tabletes 2/0.625 30 3,32 4,68 2,22 1,67 1,11 A C09BA04 07-0015-04 Noliprel Arginine 2,5mg/0,625mg Les Laboratoires Servier apvalkotas tabletes 2.5/0.625 30 4,99 6,88 2,22 1,67 1,11 A C09BA04 11-0427-02 Pricoron Duo 4mg/1,25mg Zentiva k.s. tabletes 4/1.25 30 3,60 5,05 4,13 3,10 2,07 A C09BA04 07-0370-04 Prenewel 4mg/1,25mg Krka Polska Sp.z o.o. tabletes 4/1.25 30 4,44 6,15 4,13 3,10 2,07 A C09BA04 07-0016-04 Noliprel Forte Arginine 5mg/1,25mg Les Laboratoires Servier apvalkotas tabletes 5/1.25 30 5,85 7,99 4,13 3,10 2,07 A C09BA04 07-0018-04 Prestarium Combi Arginine 5mg/1,25mg Les Laboratoires Servier apvalkotas tabletes 5/1.25 30 5,85 7,99 4,13 3,10 2,07 A C09BA04 07-0016-08 Noliprel Forte Arginine 5mg/1,25mg Les Laboratoires Servier apvalkotas tabletes 5/1.25 90 16,57 21,37 12,33 9,25 6,17 A C09BA04 10-0251-04 Prenewel 8mg/2,5mg Krka Polska Sp.z o.o. tabletes 8/2.5 30 5,71 7,81 5,16 3,87 2,58 A C09BA04 09-0050-04 Noliterax 10mg/2,5mg Les Laboratoires Servier apvalkotas tabletes 10/2.5 30 7,42 10,00 5,16 3,87 2,58 A C09BA04 09-0050-08 Noliterax 10mg/2,5mg Les Laboratoires Servier apvalkotas tabletes 10/2.5 90 20,68 26,28 15,39 11,54 7,70 A Pioglitazonum/ Metforminum A10BD05 EU/1/06/354/005 Competact Takeda Europe R&D Centre Ltd. apvalkotas tabletes 15/850 56 15,03 19,52 19,52 14,64 9,76 A R Pramipexolum N04BC05 09-0165-01 Pramipexole Portfarma 0,7mg Portfarma ehf tabletes 0.7 30 10,06 13,41 13,41 10,06 6,71 A R N04BC05 09-0270-01 Medopexol 0,7mg Medochemie Ltd. tabletes 0,7 30 11,90 15,67 13,41 10,06 6,71 A N04BC05 10-0055-01 Pramipexole Orion 0,7mg Orion Corporation tabletes 0.7 30 13,03 17,06 13,41 10,06 6,71 A N04BC05 EU/1/97/051/005 Mirapexin Boehringer Ingelheim International GmbH tabletes 0.7 30 27,54 34,35 13,41 10,06 6,71 A N04BC05 EU/1/97/051/020 Mirapexin Boehringer Ingelheim International GmbH ilgstošas darbības tabletes 1.05 30 42,43 51,86 24,16 18,12 12,08 A N04BC05 EU/1/97/051/023 Mirapexin Boehringer Ingelheim International GmbH ilgstošas darbības tabletes 2.1 30 84,86 99,80 48,28 36,21 24,14 A N04BC05 EU/1/97/051/026 Mirapexin Boehringer Ingelheim International GmbH ilgstošas darbības tabletes 3.15 30 126,07 145,96 72,36 54,27 36,18 A Quetiapinum N05AH04 10-0129-01 Quetiapine Polpharma 100mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 100 60 10,16 13,53 13,53 10,15 6,77 A R N05AH04 07-0230-05 Kventiax 100mg KRKA d.d., Novo mesto apvalkotas tabletes 100 60 10,85 14,38 13,53 10,15 6,77 A N05AH04 07-0268-09 Hedonin 100mg G.L. Pharma GmbH apvalkotas tabletes 100 60 16,60 21,40 13,53 10,15 6,77 A N05AH04 07-0373-02 Nantarid 100mg Gedeon Richter Plc. apvalkotas tabletes 100 60 16,60 21,40 13,53 10,15 6,77 A N05AH04 01-0120-02 Seroquel 100mg AstraZeneca UK Limited apvalkotas tabletes 100 60 19,18 24,49 13,53 10,15 6,77 A N05AH04 07-0096-02 Ketipinor 100mg Orion Corporation apvalkotas tabletes 100 100 12,20 16,04 16,04 12,03 8,02 A R N05AH04 09-0111-14 Quetiapine Actavis 200mg Actavis Group PCT ehf apvalkotas tabletes 200 60 13,60 17,76 17,76 13,32 8,88 A R N05AH04 07-0375-02 Nantarid 200mg Gedeon Richter Plc. apvalkotas tabletes 200 60 13,78 17,99 17,76 13,32 8,88 A N05AH04 08-0340-06 Quetiapine Teva 200mg Teva Pharma B.V. apvalkotas tabletes 200 60 13,85 18,08 17,76 13,32 8,88 A N05AH04 07-0334-04 Ketilept 200mg Egis Pharmaceuticals PLC apvalkotas tabletes 200 60 14,90 19,36 17,76 13,32 8,88 A N05AH04 10-0131-01 Quetiapine Polpharma 200mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 200 60 20,20 25,72 17,76 13,32 8,88 A N05AH04 07-0232-05 Kventiax 200mg KRKA d.d., Novo mesto apvalkotas tabletes 200 60 22,70 28,66 17,76 13,32 8,88 A N05AH04 07-0269-09 Hedonin 200mg G.L. Pharma GmbH apvalkotas tabletes 200 60 28,06 34,96 17,76 13,32 8,88 A N05AH04 01-0121-02 Seroquel 200mg AstraZeneca UK Limited apvalkotas tabletes 200 60 31,19 38,64 17,76 13,32 8,88 A N05AH04 07-0097-01 Ketipinor 200mg Orion Corporation apvalkotas tabletes 200 100 25,54 32,00 29,55 22,16 14,78 A N05AH04 07-0335-03 Ketilept 300mg Egis Pharmaceuticals PLC apvalkotas tabletes 300 30 11,17 14,77 14,77 11,08 7,39 A R N05AH04 10-0132-01 Quetiapine Polpharma 300mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 300 60 32,66 40,36 26,60 19,95 13,30 A N05AH04 07-0233-05 Kventiax 300mg KRKA d.d., Novo mesto apvalkotas tabletes 300 60 34,81 42,90 26,60 19,95 13,30 A N05AH04 07-0376-02 Nantarid 300mg Gedeon Richter Plc. apvalkotas tabletes 300 60 40,73 49,86 26,60 19,95 13,30 A N05AH04 08-0014-01 Seroquel XR 300mg AstraZeneca UK Limited ilgstošas darbības apvalkotas tabletes 300 60 57,80 69,50 31,91 23,93 15,96 A N05AH04 10-0658-04 Ketipinor 300mg Orion Corporation apvalkotas tabletes 300 100 58,77 70,58 44,25 33,19 22,13 A N05AH04 08-0015-01 Seroquel XR 400mg AstraZeneca UK Limited ilgstošas darbības apvalkotas tabletes 400 60 78,44 92,61 42,48 31,86 21,24 A Ramiprilum C09AA05 05-0572-01 Ramipril Actavis 5mg Actavis Nordic A/S tabletes 5 28 1,69 2,42 2,39 1,79 1,20 A C09AA05 07-0092-04 Polapril 5mg Pharmaceutical Works "Polpharma" S.A. cietas kapsulas 5 28 2,09 2,98 2,39 1,79 1,20 A C09AA05 05-0324-01 Hartil 5mg Egis Pharmaceuticals PLC tabletes 5 28 2,45 3,46 2,39 1,79 1,20 A C09AA05 99-0108-01 Cardace 5mg Sanofi-Aventis Latvia SIA tabletes 5 28 3,00 4,27 2,39 1,79 1,20 A C09AA05 09-0040-05 Ramimed 5mg Medochemie Ltd. tabletes 5 30 1,79 2,56 2,56 1,92 1,28 A R C09AA05 04-0388-04 Ramicor 5mg Hexal AG tabletes 5 30 1,83 2,62 2,56 1,92 1,28 A C09AA05 05-0427-01 Ampril 5mg KRKA d.d., Novo mesto tabletes 5 30 2,63 3,71 2,56 1,92 1,28 A C09AA05 99-0108-12 Cardace 5mg Sanofi-Aventis Latvia SIA tabletes 5 56 5,90 8,05 4,70 3,53 2,35 A C09AA05 99-0108-02 Cardace 5mg Sanofi-Aventis Latvia SIA tabletes 5 98 10,43 13,85 8,04 6,03 4,02 A C09AA05 05-0573-01 Ramipril Actavis 10mg Actavis Nordic A/S tabletes 10 28 3,05 4,33 4,19 3,14 2,10 A C09AA05 07-0093-04 Polapril 10mg Pharmaceutical Works "Polpharma" S.A. cietas kapsulas 10 28 3,06 4,35 4,19 3,14 2,10 A C09AA05 03-0067-01 Cardace 10mg Sanofi-Aventis Latvia SIA tabletes 10 28 4,10 5,71 4,19 3,14 2,10 A C09AA05 05-0325-01 Hartil 10mg Egis Pharmaceuticals PLC tabletes 10 28 5,22 7,17 4,19 3,14 2,10 A C09AA05 09-0041-05 Ramimed 10mg Medochemie Ltd. tabletes 10 30 3,17 4,49 4,49 3,37 2,25 A R C09AA05 05-0428-01 Ampril 10mg KRKA d.d., Novo mesto tabletes 10 30 5,34 7,32 4,49 3,37 2,25 A C09AA05 03-0067-12 Cardace 10mg Sanofi-Aventis Latvia SIA tabletes 10 56 7,99 10,74 8,06 6,05 4,03 A C09AA05 04-0389-08 Ramicor 10mg Hexal AG tabletes 10 60 7,21 9,73 8,64 6,48 4,32 A Ramiprilum/ Hydrochloro-thiazidum C09BA05 07-0083-05 Hartil HCT 5/25mg Egis Pharmaceuticals PLC tabletes 5/25 28 4,71 6,51 5,18 3,89 2,59 A C09BA05 08-0076-05 Ramimed HCT 5mg/25mg Medochemie Ltd. tabletes 5/25 30 4,11 5,72 5,55 4,16 2,78 A C09BA05 05-0553-03 Ampril HD 5mg/25mg KRKA d.d., Novo mesto tabletes 5/25 30 4,33 6,01 5,55 4,16 2,78 A C09BA05 04-0184-01 Co-Ramicor 5mg/25mg Hexal AG tabletes 5/25 30 4,90 6,75 5,55 4,16 2,78 A Repaglinidum A10BX02 11-0016-02 Reneos 1mg Zentiva k.s. tabletes 1 90 7,60 10,24 9,26 6,95 4,63 A A10BX02 EU/1/98/076/012 NovoNorm Novo Nordisk A/S tabletes 1 90 10,87 14,40 9,26 6,95 4,63 A A10BX02 11-0017-02 Reneos 2mg Zentiva k.s. tabletes 2 90 10,26 13,65 12,33 9,25 6,17 A A10BX02 EU/1/98/076/019 NovoNorm Novo Nordisk A/S tabletes 2 90 14,66 19,07 12,33 9,25 6,17 A Rilmenidinum C02AC06 10-0523-02 Rilmenidine Teva 1mg Teva Pharma B.V. tabletes 1 30 2,77 3,89 3,89 2,92 1,95 A R C02AC06 02-0344-01 Tenaxum 1mg Les Laboratoires Servier tabletes 1 30 4,50 6,24 3,89 2,92 1,95 A C02AC06 02-0344-02 Tenaxum 1mg Les Laboratoires Servier tabletes 1 90 11,70 15,42 11,61 8,71 5,81 A Risperidonum N05AX08 06-0296-04 Torendo Q-Tab 2mg KRKA d.d., Novo mesto mutē disperģējamas tabletes 2 30 7,61 10,25 6,34 4,76 3,17 A N05AX08 07-0185-02 Rispaxol 2mg Grindeks AS apvalkotas tabletes 2 60 7,83 10,53 10,53 7,90 5,27 A R N05AX08 07-0207-05 Medorisper 2mg Medochemie Ltd. apvalkotas tabletes 2 60 8,37 11,23 10,53 7,90 5,27 A N05AX08 98-0100-01 Rispolept 2mg UAB Johnson & Johnson apvalkotas tabletes 2 60 12,22 16,06 10,53 7,90 5,27 A N05AX08 98-0101-01 Rispolept 3mg UAB Johnson & Johnson apvalkotas tabletes 3 60 18,74 23,97 15,77 11,83 7,89 A N05AX08 07-0186-02 Rispaxol 4mg Grindeks AS apvalkotas tabletes 4 60 16,66 21,48 20,98 15,74 10,49 A N05AX08 07-0209-05 Medorisper 4mg Medochemie Ltd. apvalkotas tabletes 4 60 17,10 22,01 20,98 15,74 10,49 A N05AX08 98-0102-01 Rispolept 4mg UAB Johnson & Johnson apvalkotas tabletes 4 60 24,82 31,15 20,98 15,74 10,49 A N05AX08 I000051-01 Rispolept 1mg/ml ELPIS SIA (paralēlais importētājs) šķīdums iekšķīgai lietošanai 1mg/ml 100ml 12,39 16,27 16,27 12,20 8,14 A PR N05AX08 01-0372-02 Rispolept 1mg/ml UAB Johnson & Johnson šķīdums iekšķīgai lietošanai 1mg/ml 100ml 13,77 17,98 16,27 12,20 8,14 A Ropinirolum N04BC04 08-0263-02 Ropinirol Orion 0,25mg Orion Corporation apvalkotas tabletes 0,25 84 2,64 3,72 2,77 2,08 1,39 A N04BC04 08-0265-02 Ropinirol Orion 1mg Orion Corporation apvalkotas tabletes 1 84 11,25 14,87 11,07 8,30 5,54 A N04BC04 11-0085-02 Rolpryna SR 2mg KRKA d.d., Novo mesto ilgstošas darbības tabletes 2 28 5,39 7,39 7,39 5,54 3,70 A R N04BC04 06-0261-06 Requip-Modutab 2mg GlaxoSmithKline Latvia SIA ilgstošas darbības tabletes 2 28 7,88 10,60 7,39 5,54 3,70 A N04BC04 11-0085-04 Rolpryna SR 2mg KRKA d.d., Novo mesto ilgstošas darbības tabletes 2 84 16,86 21,72 21,72 16,29 10,86 A R N04BC04 08-0266-02 Ropinirol Orion 2mg Orion Corporation apvalkotas tabletes 2 84 21,10 26,78 22,12 16,59 11,06 A N04BC04 06-0261-08 Requip-Modutab 2mg GlaxoSmithKline Latvia SIA ilgstošas darbības tabletes 2 84 24,48 30,74 21,72 16,29 10,86 A N04BC04 06-0263-03 Requip-Modutab 4mg GlaxoSmithKline Latvia SIA ilgstošas darbības tabletes 4 28 15,43 20,00 14,77 11,08 7,39 A N04BC04 11-0086-04 Rolpryna SR 4mg KRKA d.d., Novo mesto ilgstošas darbības tabletes 4 84 34,76 42,84 42,84 32,13 21,42 A R N04BC04 06-0263-04 Requip-Modutab 4mg GlaxoSmithKline Latvia SIA ilgstošas darbības tabletes 4 84 49,32 59,96 42,84 32,13 21,42 A N04BC04 08-0267-02 Ropinirol Orion 5mg Orion Corporation apvalkotas tabletes 5 84 47,52 57,85 55,23 41,42 27,62 A N04BC04 11-0087-04 Rolpryna SR 8mg KRKA d.d., Novo mesto ilgstošas darbības tabletes 8 84 68,32 81,28 81,28 60,96 40,64 A R N04BC04 06-0264-04 Requip-Modutab 8mg GlaxoSmithKline Latvia SIA ilgstošas darbības tabletes 8 84 96,56 112,91 81,28 60,96 40,64 A Rosuvastatinum C10AA07 10-0162-04 Rosuvastatin Teva 10mg Teva Pharma B.V. apvalkotas tabletes 10 28 2,32 3,28 2,74 2,06 1,37 A C10AA07 03-0167-02 Crestor 10mg AstraZeneca UK Limited apvalkotas tabletes 10 28 10,61 14,08 2,74 2,06 1,37 A C10AA07 11-0352-01 Romazic 10mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 10 30 2,54 3,58 2,94 2,21 1,47 A C10AA07 10-0178-01 Zaranta 10mg Gedeon Richter Plc. apvalkotas tabletes 10 30 3,77 5,28 2,94 2,21 1,47 A C10AA07 10-0007-02 Rosuvacard 10mg Zentiva k.s. apvalkotas tabletes 10 30 4,90 6,75 2,94 2,21 1,47 A C10AA07 11-0028-04 Sorvasta 15mg KRKA d.d., Novo mesto apvalkotas tabletes 15 28 2,82 3,95 3,95 2,96 1,98 A R C10AA07 11-0029-04 Sorvasta 20mg KRKA d.d., Novo mesto apvalkotas tabletes 20 28 3,80 5,32 5,21 3,91 2,61 A C10AA07 10-0163-04 Rosuvastatin Teva 20mg Teva Pharma B.V. apvalkotas tabletes 20 28 4,99 6,88 5,21 3,91 2,61 A C10AA07 03-0168-02 Crestor 20mg AstraZeneca UK Limited apvalkotas tabletes 20 28 16,57 21,37 5,21 3,91 2,61 A C10AA07 11-0353-01 Romazic 20mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 20 30 5,20 7,15 5,58 4,19 2,79 A C10AA07 10-0179-01 Zaranta 20mg Gedeon Richter Plc. apvalkotas tabletes 20 30 7,42 10,00 5,58 4,19 2,79 A C10AA07 10-0008-02 Rosuvacard 20mg Zentiva k.s. apvalkotas tabletes 20 30 9,18 12,28 5,58 4,19 2,79 A C10AA07 11-0030-04 Sorvasta 30mg KRKA d.d., Novo mesto apvalkotas tabletes 30 28 6,30 8,57 7,73 5,80 3,87 A C10AA07 11-0031-04 Sorvasta 40mg KRKA d.d., Novo mesto apvalkotas tabletes 40 28 8,26 11,09 10,19 7,64 5,10 A C10AA07 03-0169-02 Crestor 40mg AstraZeneca UK Limited apvalkotas tabletes 40 28 28,17 35,09 10,19 7,64 5,10 A C10AA07 10-0009-02 Rosuvacard 40mg Zentiva k.s. apvalkotas tabletes 40 30 9,87 13,16 10,92 8,19 5,46 A C10AA07 10-0180-01 Zaranta 40mg Gedeon Richter Plc. apvalkotas tabletes 40 30 9,98 13,31 10,92 8,19 5,46 A Sertralinum N06AB06 06-0026-01 Sertralin Actavis 50mg Actavis Nordic A/S apvalkotas tabletes 50 28 2,02 2,88 2,88 2,16 1,44 A R N06AB06 97-0311-01 Zoloft 50mg Pfizer Limited apvalkotas tabletes 50 28 7,85 10,56 2,88 2,16 1,44 A N06AB06 06-0216-01 Sertraline-Teva 50mg Teva Pharma B.V. apvalkotas tabletes 50 30 2,60 3,66 3,09 2,32 1,55 A N06AB06 05-0217-04 Sertraline Lannacher 50mg G.L. Pharma GmbH apvalkotas tabletes 50 30 4,10 5,71 3,09 2,32 1,55 A N06AB06 02-0359-01 Stimuloton 50mg Egis Pharmaceuticals PLC apvalkotas tabletes 50 30 5,00 6,89 3,09 2,32 1,55 A Simvastatinum C10AA01 03-0043-01 Simgal 10mg TEVA Czech Industries s.r.o. apvalkotas tabletes 10 28 2,29 3,25 0,45 0,34 0,23 A C10AA01 03-0044-01 Simgal 20mg TEVA Czech Industries s.r.o. apvalkotas tabletes 20 28 4,54 6,28 0,90 0,68 0,45 A C10AA01 02-0416-01 Simvacor 20mg Hexal AG apvalkotas tabletes 20 30 1,93 2,76 0,96 0,72 0,48 A C10AA01 03-0045-01 Simgal 40mg TEVA Czech Industries s.r.o. apvalkotas tabletes 40 28 9,40 12,56 1,79 1,34 0,90 A Sitagliptinum A10BH01 EU/1/07/383/014 Januvia Merck Sharp & Dohme Ltd. apvalkotas tabletes 100 28 24,36 30,61 30,61 22,96 15,31 B Tamsulosinum G04CA02 05-0554-01 Tanyz 0,4 mg KRKA d.d., Novo mesto ilgstošas darbības cietas kapsulas 0,4 30 2,88 4,04 4,04 3,03 2,02 A R G04CA02 06-0038-01 Fokusin 0,4mg Zentiva k.s. ilgstošas darbības cietas kapsulas 0,4 30 3,00 4,27 4,04 3,03 2,02 A G04CA02 06-0089-01 Omsal 0,4mg Gedeon Richter Plc. ilgstošas darbības cietas kapsulas 0,4 30 4,51 6,25 4,04 3,03 2,02 A G04CA02 06-0109-01 Tamsulosin Lannacher 0,4mg Lannacher Heilmittel GmbH ilgstošas darbības cietas kapsulas 0,4 30 4,79 6,61 4,04 3,03 2,02 A G04CA02 06-0031-01 Flosin 0,4mg Menarini International Operations Luxembourg S.A. ilgstošas darbības cietas kapsulas 0,4 30 8,27 11,10 4,04 3,03 2,02 A G04CA02 05-0100-05 Omnic Tocas 0,4mg Astellas Pharma Europe B.V. ilgstošas darbības tabletes 0,4 30 8,41 11,28 4,04 3,03 2,02 A Telmisartanum C09CA07 EU/1/10/639/012 Telmisartan Actavis Actavis Group PCT ehf tabletes 40 28 2,22 3,15 2,55 1,91 1,28 A C09CA07 10-0505-05 Telmisartan-ratiopharm 40mg Ratiopharm GmbH tabletes 40 28 2,40 3,39 2,55 1,91 1,28 A C09CA07 10-0651-06 Telmisartan Sandoz 40mg Sandoz d.d. tabletes 40 28 2,56 3,61 2,55 1,91 1,28 A C09CA07 EU/1/10/632/009 Tolura 40mg KRKA d.d., Novo mesto tabletes 40 28 3,12 4,42 2,55 1,91 1,28 A C09CA07 EU/1/98/089/002 Pritor Bayer Schering Pharma AG tabletes 40 28 5,19 7,13 2,55 1,91 1,28 A C09CA07 EU/1/98/090/002 Micardis 40mg Boehringer Ingelheim International GmbH tabletes 40 28 9,79 13,06 2,55 1,91 1,28 A C09CA07 10-0174-01 Tezeo 40mg Zentiva k.s. tabletes 40 30 4,15 5,78 2,73 2,05 1,37 A C09CA07 10-0506-05 Telmisartan-ratiopharm 80mg Ratiopharm GmbH tabletes 80 28 3,69 5,17 4,85 3,64 2,43 A C09CA07 EU/1/10/639/022 Telmisartan Actavis Actavis Group PCT ehf tabletes 80 28 4,14 5,76 4,85 3,64 2,43 A C09CA07 10-0652-06 Telmisartan Sandoz 80mg Sandoz d.d. tabletes 80 28 4,77 6,59 4,85 3,64 2,43 A C09CA07 EU/1/10/632/016 Tolura 80mg KRKA d.d., Novo mesto tabletes 80 28 5,86 8,00 4,85 3,64 2,43 A C09CA07 EU/1/98/089/007 Pritor Bayer Schering Pharma AG tabletes 80 28 6,66 9,03 4,85 3,64 2,43 A C09CA07 EU/1/98/090/006 Micardis 80mg Boehringer Ingelheim International GmbH tabletes 80 28 12,36 16,24 4,85 3,64 2,43 A C09CA07 10-0175-01 Tezeo 80mg Zentiva k.s. tabletes 80 30 6,14 8,36 5,20 3,90 2,60 A Telmisartanum/ Amlodipinum C09DB04 EU/1/10/648/002 Twynsta Boehringer Ingelheim International GmbH tabletes 40/5 28 14,84 19,29 3,86 2,90 1,93 A C09DB04 EU/1/10/648/009 Twynsta Boehringer Ingelheim International GmbH tabletes 40/10 28 15,73 20,36 4,65 3,49 2,33 A C09DB04 EU/1/10/648/016 Twynsta Boehringer Ingelheim International GmbH tabletes 80/5 28 17,93 23,00 6,16 4,62 3,08 A C09DB04 EU/1/10/648/023 Twynsta Boehringer Ingelheim International GmbH tabletes 80/10 28 18,82 24,07 6,94 5,21 3,47 A Topiramatum N03AX11 10-0507-03 Topiramate Portfarma 25mg Portfarma ehf apvalkotas tabletes 25 60 3,20 4,52 4,52 3,39 2,26 A R N03AX11 10-0301-01 Topiramate Pfizer 25mg Pfizer Europe MA EEIG apvalkotas tabletes 25 60 3,47 4,88 4,52 3,39 2,26 A N03AX11 00-0120-02 Topamax 25mg UAB Johnson & Johnson apvalkotas tabletes 25 60 4,40 6,10 4,52 3,39 2,26 A N03AX11 08-0283-01 Topiramat Orion 25mg Orion Corporation apvalkotas tabletes 25 60 4,40 6,10 4,52 3,39 2,26 A N03AX11 10-0508-03 Topiramate Portfarma 50mg Portfarma ehf apvalkotas tabletes 50 60 6,25 8,50 8,50 6,38 4,25 A R N03AX11 10-0302-01 Topiramate Pfizer 50mg Pfizer Europe MA EEIG apvalkotas tabletes 50 60 7,25 9,79 8,50 6,38 4,25 A N03AX11 00-0121-02 Topamax 50mg UAB Johnson & Johnson apvalkotas tabletes 50 60 9,12 12,20 8,50 6,38 4,25 A N03AX11 08-0284-01 Topiramat Orion 50mg Orion Corporation apvalkotas tabletes 50 60 9,12 12,20 8,50 6,38 4,25 A N03AX11 10-0509-03 Topiramate Portfarma 100mg Portfarma ehf apvalkotas tabletes 100 60 12,39 16,27 16,27 12,20 8,14 A R N03AX11 08-0285-01 Topiramat Orion 100mg Orion Corporation apvalkotas tabletes 100 60 17,52 22,51 16,27 12,20 8,14 A N03AX11 00-0122-02 Topamax 100mg UAB Johnson & Johnson apvalkotas tabletes 100 60 17,52 22,51 16,27 12,20 8,14 A N03AX11 10-0303-01 Topiramate Pfizer 100mg Pfizer Europe MA EEIG apvalkotas tabletes 100 60 13,76 17,96 16,27 12,20 8,14 A N03AX11 10-0510-03 Topiramate Portfarma 200mg Portfarma ehf apvalkotas tabletes 200 60 27,41 34,19 32,52 24,39 16,26 A N03AX11 08-0286-01 Topiramat Orion 200mg Orion Corporation apvalkotas tabletes 200 60 36,52 44,91 32,52 24,39 16,26 A Topotecanum L01XX17 EU/1/10/660/001 Potactasol Actavis Group PCT ehf pulveris infūziju šķīduma koncentrāta pagatavošanai 1 1 12,66 16,61 16,61 12,46 8,31 A R L01XX17 EU/1/96/027/005 Hycamtin SmithKline Beecham plc pulveris infūziju šķīduma koncentrāta pagatavošanai 1 1 20,37 25,92 16,61 12,46 8,31 A L01XX17 EU/1/09/552/002 Topotecan Teva Teva Pharma B.V. koncentrāts infūziju šķīduma pagatavošanai 1mg/ml 5 76,00 89,88 83,05 62,29 41,53 A Travoprostum S01EE04 EU/1/01/199/001 Travatan Alcon Laboratories (UK) Ltd. acu pilieni, šķīdums 0.04mg/ ml-2.5ml 1 gab. 8,83 11,82 4,02 3,02 2,01 A Travoprostum/ Timololum S01ED51 EU/1/06/338/001 DuoTrav Alcon Laboratories (UK) Ltd. acu pilieni, šķīdums 0.04/5mg/ ml-2.5ml 1 gab. 10,84 14,36 5,12 3,84 2,56 A Triptorelinum L02AE04 98-0005-01 Diphereline 3,75mg Ipsen Pharma ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 3,75 1 58,95 70,78 70,78 53,09 35,39 A R L02AE04 03-0240-01 Diphereline 11,25mg Ipsen Pharma ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 11,25 1 173,01 198,53 198,53 148,90 99,27 A R Valsartanum C09CA03 10-0438-01 Vanatex 80mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 80 28 2,68 3,77 2,55 1,91 1,28 A C09CA03 07-0195-03 Valsacor 80mg KRKA d.d., Novo mesto apvalkotas tabletes 80 28 2,78 3,91 2,55 1,91 1,28 A C09CA03 10-0220-03 VALZAP 80mg Zentiva k.s. apvalkotas tabletes 80 28 2,93 4,11 2,55 1,91 1,28 A C09CA03 02-0391-01 Diovan 80mg Novartis Finland Oy apvalkotas tabletes 80 28 12,29 16,15 2,55 1,91 1,28 A C09CA03 10-0437-01 Vanatex 160mg Pharmaceutical Works "Polpharma" S.A. apvalkotas tabletes 160 28 3,75 5,25 4,85 3,64 2,43 A C09CA03 07-0196-03 Valsacor 160mg KRKA d.d., Novo mesto apvalkotas tabletes 160 28 3,83 5,35 4,85 3,64 2,43 A C09CA03 10-0221-03 VALZAP 160mg Zentiva k.s. apvalkotas tabletes 160 28 4,50 6,24 4,85 3,64 2,43 A C09CA03 02-0392-01 Diovan 160mg Novartis Finland Oy apvalkotas tabletes 160 28 14,89 19,35 4,85 3,64 2,43 A Venlafaxinum N06AX16 09-0152-01 Venlafaxine Orion 75mg Orion Corporation ilgstošas darbības cietas kapsulas 75 28 5,66 7,74 5,67 4,25 2,84 A N06AX16 08-0324-04 Venlafaxin-ratiopharm 75mg Ratiopharm GmbH ilgstošas darbības cietas kapsulas 75 30 4,38 6,07 6,07 4,55 3,04 A R N06AX16 07-0086-03 Elify XR 75mg Medochemie Ltd. ilgstošas darbības cietas kapsulas 75 30 4,76 6,57 6,07 4,55 3,04 A N06AX16 07-0087-03 Elify XR 150mg Medochemie Ltd. ilgstošas darbības cietas kapsulas 150 30 9,82 13,09 12,11 9,08 6,06 A Vinorelbinum L01CA04 08-0156-03 Vinorelbine Actavis 50mg/5ml Actavis Group PTC ehf koncentrāts infūziju šķīduma pagatavošanai 50mg/ 5ml 1 48,60 59,11 59,11 44,33 29,56 A R L01CA04 06-0298-01 Vinorelbin "Ebewe" 50mg/5ml Ebewe Pharma GmbH, Nfg.KG koncentrāts infūziju šķīduma pagatavošanai 50mg/ 5ml 1 57,01 68,61 59,11 44,33 29,56 A L01CA04 99-0347-06 Navelbine 10mg/ml Pierre Fabre Medicament koncentrāts infūziju šķīduma pagatavošanai 50mg/ 5ml 1 64,44 76,93 59,11 44,33 29,56 A Nacionālā veselības dienesta direktors M.Taube 4.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Kompensācijas bāzes cenas un/vai references cenas maiņa Kompensējamo zāļu saraksta medicīniskajām ierīcēm Medicīniskā ierīce Identifikācijas Nr. Medicīniskās ierīces nosaukums Iesniedzējs Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar 12% PVN (Ls) Kompensācijas summa (Ls) Saraksta kategorija Pazīme References cena 100% 75% 50% Glikēmijas teststrēmeles 10/01-001/01-01 Accu-Chek Active Roche Lietuva UAB 25 4,52 6,26 5,24 3,93 2,62 A 10/01-002/02-01 FreeStyle Optium Abbott Laboratories Baltics SIA 25 4,85 6,69 5,24 3,93 2,62 A 10/01-012/14-01 MediSmart Sapphire Linus Medical, SIA 25 5,25 7,21 5,24 3,93 2,62 A 12/01-001/16-01 Rightest GS 300 Medhouse Baltic SIA 50 8,35 11,20 10,47 7,85 5,24 A 10/01-001/01-02 Accu-Chek Active Roche Lietuva UAB 50 8,38 11,24 10,47 7,85 5,24 A 10/01-012/14-02 MediSmart Sapphire Linus Medical, SIA 50 8,39 11,26 10,47 7,85 5,24 A 10/01-003/03-01 On-Call Plus AMD Grupa SIA 50 8,83 11,82 10,47 7,85 5,24 A 10/01-004/02-01 FreeStyle Papillon Abbott Laboratories Baltics SIA 50 9,70 12,95 10,47 7,85 5,24 A 10/01-005/02-01 FreeStyle Optium Abbott Laboratories Baltics SIA 50 9,70 12,95 10,47 7,85 5,24 A 10/01-007/05-01 Contour TS Bayer SIA 50 10,43 13,85 10,47 7,85 5,24 A 10/01-008/01-01 Accu-Chek Go Roche Lietuva UAB 50 11,00 14,56 10,47 7,85 5,24 A 10/01-009/01-01 Accu-Chek Performa Roche Lietuva UAB 50 11,00 14,56 10,47 7,85 5,24 A 10/01-006/04-01 Glucocard X Sensor OneMed SIA 50 11,55 15,24 10,47 7,85 5,24 A Nacionālā veselības dienesta direktors M.Taube 5.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Saraksta kategorijas maiņa Kompensējamo zāļu saraksta zālēm Zāļu vispārīgais nosaukums ATĶ kodi Zāļu identifikācijas Nr. Zāļu nosaukums Reģistrācijas apliecības īpašnieks Forma Stiprums (mg) Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar PVN 12% (Ls) Kompensācijas summa (Ls) Saraksta kategorija Zāļu pazīme References cena 100% 75% 50% 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Amisulpridum N05AL05 99-0625-01 Solian 200mg Sanofi-Aventis Latvia SIA tabletes 200 30 10,67 14,16 14,16 10,62 7,08 A R N05AL05 I000144-01 Solian 400mg ELPIS SIA (paralēlais importētājs) apvalkotas tabletes 400 30 18,80 24,05 24,05 18,04 12,03 A PR N05AL05 02-0276-01 Solian 400mg Sanofi-Aventis Latvia SIA apvalkotas tabletes 400 30 20,89 26,52 24,05 18,04 12,03 A N05AL05 09-0346-01 Solian 100mg/ml Sanofi-Aventis Latvia SIA šķīdums iekšķīgai lietošanai 6000mg/ 60ml 1 22,65 28,59 19,83 14,87 9,92 A Buspironum N05BE01 00-0553-01 Spitomin 5mg Egis Pharmaceuticals Ltd. tabletes 5 60 2,96 4,14 4,14 3,11 2,07 A R N05BE01 00-0554-01 Spitomin 10mg Egis Pharmaceuticals Ltd. tabletes 10 60 4,29 5,96 4,27 3,20 2,14 A Levetiracetamum N03AX14 12-0056-03 Levetiracetam PharmaSwiss 250mg PharmaSwiss Česka Republika s.r.o. apvalkotas tabletes 250 30 7,52 10,14 7,22 5,42 3,61 A N03AX14 12-0057-03 Levetiracetam PharmaSwiss 500mg PharmaSwiss Česka Republika s.r.o. apvalkotas tabletes 500 30 14,76 19,20 13,73 10,30 6,87 A N03AX14 12-0058-03 Levetiracetam PharmaSwiss 750mg PharmaSwiss Česka Republika s.r.o. apvalkotas tabletes 750 30 21,81 27,61 20,58 15,44 10,29 A N03AX14 12-0059-03 Levetiracetam PharmaSwiss 1000mg PharmaSwiss Česka Republika s.r.o. apvalkotas tabletes 1000 30 28,96 36,02 25,79 19,34 12,90 A Levomepromazinum N05AA02 98-0662-01 Tisercin 25mg Egis Pharmaceuticals Ltd. apvalkotas tabletes 25 50 2,41 3,40 2,42 1,82 1,21 A Methotrexatum L01BA01 05-0313-02 Methotrexat "Ebewe" 2,5mg Ebewe Pharma GmbH tabletes 2.5 50 3,83 5,35 5,35 4,01 2,68 B L01BA01 05-0314-02 Methotrexat "Ebewe" 5mg Ebewe Pharma GmbH tabletes 5 50 7,52 10,14 10,14 7,61 5,07 B Methyl-prednisolonum H02AB04 99-1042-02 Medrol 4mg Pfizer Europe MA EEIG tabletes 4 100 4,76 6,57 6,57 4,93 3,29 A R H02AB04 I000101-01 Medrol 16mg ELPIS SIA (paralēlais importētājs) tabletes 16 14 2,10 2,99 2,99 2,24 1,50 A PR H02AB04 99-1043-01 Medrol 16mg Pfizer Europe MA EEIG tabletes 16 50 8,32 11,17 10,56 7,92 5,28 A Nitrendipinum C08CA08 97-0654-01 Lusopress 20mg Istituto Luso Farmaco D Italia S.p.A. tabletes 20 28 2,80 3,93 2,72 2,04 1,36 A Pioglitazonum A10BG03 EU/1/00/150/001 Actos Takeda Europe R&D Centre Ltd. tabletes 15 28 14,72 19,14 13,70 10,28 6,85 A A10BG03 EU/1/00/150/004 Actos Takeda Europe R&D Centre Ltd. tabletes 30 28 22,35 28,25 18,10 13,58 9,05 A Tolperisonum M03BX04 97-0349-01 Mydocalm 150mg Gedeon Richter Plc. apvalkotas tabletes 150 30 3,03 4,31 3,01 2,26 1,51 A Triptorelinum L02AE04 98-0005-01 Diphereline 3,75mg Ipsen Pharma ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 3,75 1 58,95 70,78 70,78 53,09 35,39 A R L02AE04 I000164-01 Diphereline SR 3,75mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 3,75 1 62,42 74,67 70,78 53,09 35,39 A P L02AE04 03-0240-01 Diphereline 11,25mg Ipsen Pharma ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 11,25 1 173,01 198,53 198,53 148,90 99,27 A R L02AE04 I000165-01 Diphereline SR 11,25mg Scandic Pharma SIA (paralēlais importētājs) ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 11,25 1 194,50 222,60 198,53 148,90 99,27 A P L02AE04 I000163-01 Diphereline SR 11,25mg ELPIS SIA (paralēlais importētājs) ilgstošas darbības pulveris un šķīdinātājs injekciju suspensijas pagatavošanai 11,25 1 194,50 222,60 198,53 148,90 99,27 A P Nacionālā veselības dienesta direktors M.Taube 6.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 Identifikācijas numura maiņa Kompensējamo zāļu saraksta zālēm Zāļu vispārīgais nosaukums ATC kods Zāļu identifikācijas Nr. Jaunais zāļu identifikācijas Nr. Zāļu nosaukums Reģ. apl. īpašnieks Forma Stiprums (mg) Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar PVN 12% (Ls) Kompensācijas summa (Ls) Saraksta kategorija Medikamentu pazīme References cena (100%) 75% 50% 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Abacavirum/ Lamivudinum/ Zidovudinum J05AR04 EU/1/00/156/002 EU/1/00/156/004 Trizivir Glaxo Group Ltd apvalkotas tabletes 300/150/ 300 60 346,23 392,54 392,54 294,41 196,27 A R Calcii folinatum V03AF03 99-0864-02 99-0863-02 Leucovorin-Teva 10mg/ml Teva Pharma B.V. šķīdums injekcijām 100mg/ 10ml 1 4,25 5,90 5,90 4,43 2,95 B Calcitriolum A11CC04 96-0198-01 96-0198-03 Rocaltrol 0,25mcg Roche Latvija SIA mīkstas kapsulas 0.00025 30 5,97 8,14 8,14 6,11 4,07 A R Clopidogrelum B01AC04 09-0443-02 09-0443-14 Plavocorin 75mg Sandoz d.d. apvalkotas tabletes 75 28 5,31 7,29 3,07 2,30 1,54 A Leflunomidum L04AA13 EU/1/99/118/001 EU/1/99/118/003 Arava Sanofi-Aventis Deutschland GmbH apvalkotas tabletes 10 30 15,68 20,31 17,07 12,80 8,54 A L04AA13 EU/1/99/118/005 EU/1/99/118/007 Arava Sanofi-Aventis Deutschland GmbH apvalkotas tabletes 20 30 30,88 38,27 34,13 25,60 17,07 A Natrii valproatum N03AG01 03-0393-02 03-0393-06 Convulex retard 300mg G.L. Pharma GmbH ilgstošas darbības tabletes 300 100 7,51 10,12 6,83 5,12 3,42 A N03AG01 03-0394-01 03-0394-05 Convulex retard 500mg G.L. Pharma GmbH ilgstošas darbības tabletes 500 50 6,58 8,93 6,83 5,12 3,42 A Paclitaxelum L01CD01 05-0317-01 05-0316-02 Paclitaxel-Teva 6mg/ml Pharmachemie B.V. koncentrāts infūziju šķīduma pagatavošanai 100mg/ 16.7ml 1 57,01 68,61 39,87 29,90 19,94 A Pancreatinum A09AA02 98-0222-02 98-0222-04 Pangrol 25 000 V Berlin-Chemie AG/ Menarini Group zarnās šķīstošas cietas kapsulas 25 000 EFV 20 4,85 6,69 6,69 5,02 3,35 A R Propranololum C07AA05 95-0001-01 95-0001-02 Anaprilīns 10mg Olainfarm A/S tabletes 10 50 1,32 1,90 1,90 1,43 0,95 B Vildagliptinum/ Metforminum A10BD08 EU/1/07/425/011 EU/1/07/425/017 Eucreas Novartis Europharm Limited apvalkotas tabletes 50/1000 180 88,15 103,49 103,49 77,62 51,75 B Nacionālā veselības dienesta direktors M.Taube 7.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 No Kompensējamo zāļu saraksta svītrotās zāles Zāļu vispārīgais nosaukums Zāļu identifikācijas Nr. Zāļu nosaukums Reģ. apl. īpašnieks Forma Stiprums (mg) Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar PVN 12% (Ls) Kompensācijas summa (Ls) Saraksta kategorija References cena 100% 75% 50% 1 2 3 4 5 6 7 8 9 10 11 12 13 Amlodipinum 09-0033-01 Amlodipin Olainfarm 5mg OL tabletes 5 30 1,43 2,06 1,66 1,25 0,83 A 09-0034-01 Amlodipin Olainfarm 10mg OL tabletes 10 30 2,30 3,26 2,63 1,97 1,32 A Clarithromycinum 98-0772-01 Fromilid 500mg KR apvalkotas tabletes 500 14 10,08 13,43 9,99 7,49 5,00 A Clopidogrelum 09-0387-01 Egitromb 75mg EG apvalkotas tabletes 75 28 10,03 13,36 4,32 3,24 2,16 A Doxazosinum 01-0117-01 Doxagamma 4mg WP tabletes 4 20 4,27 5,94 4,83 3,62 2,42 A Erythropoietinum 02-0253-01 Eprex 2000IU/0,5ml JO šķīdums injekcijām pilnšļircēs 2 000IU/ 0.5ml 6 47,34 57,64 48,96 36,72 24,48 A 02-0254-01 Eprex 4000IU/0,4ml JO šķīdums injekcijām pilnšļircēs 4 000IU/ 0.4ml 6 93,83 109,85 93,20 69,90 46,60 A 01-0405-01 Eprex 6000IU/0,6ml JO šķīdums injekcijām pilnšļircēs 6 000IU/ 0.6ml 6 139,02 160,46 136,01 102,01 68,01 A 02-0255-01 Eprex 10 000IU/ml JO šķīdums injekcijām pilnšļircēs 10 000IU/ ml 6 214,33 244,81 207,73 155,80 103,87 A Escitalopramum 09-0435-04 Escitalopram-ratiopharm 20mg RP apvalkotas tabletes 20 30 10,99 14,55 9,72 7,29 4,86 A Glimepiridum 08-0199-01 Glimasol 1mg OL tabletes 1 30 0,99 1,44 1,28 0,96 0,64 A 08-0200-01 Glimasol 2mg OL tabletes 2 30 1,90 2,72 2,52 1,89 1,26 A 08-0202-01 Glimasol 4mg OL tabletes 4 30 3,75 5,25 3,77 2,83 1,89 A Lacidipinum I000158-01 Lacipil 4mg EP apvalkotas tabletes 4 14 2,10 2,99 2,99 2,24 1,50 A Metoprololum 09-0169-04 Metoprolol Polpharma 190mg PO ilgstošas darbības tabletes 200* 28 4,98 6,87 6,53 4,90 3,27 A Methotrexatum 09-0058-07 Trexan 2,5mg OR tabletes 2.5 30 1,91 2,73 2,73 2,05 1,37 A 09-0059-01 Trexan 10mg OR tabletes 10 10 2,51 3,54 3,54 2,66 1,77 A Paclitaxelum 08-0295-02 Paclitaxel SanoSwiss 6mg/ml SW koncentrāts infūziju šķīduma pagatavošanai 100mg/ 16.7ml 1 44,93 54,80 50,47 37,85 25,24 A 03-0396-01 Paclitaxel "Ebewe" 100mg/16,7ml EW koncentrāts infūziju šķīduma pagatavošanai 100mg/ 16.7ml 1 88,32 103,68 50,47 37,85 25,24 A Rosuvastatinum 11-0027-04 Sorvasta 10mg MM apvalkotas tabletes 10 28 2,86 4,01 3,42 2,57 1,71 A Tamsulosinum 06-0038-02 Fokusin 0,4mg ZE ilgstošas darbības cietas kapsulas 0,4 90 13,29 17,38 14,13 10,60 7,07 A Temozolomidum EU/1/98/096/003 Temodal MS cietas kapsulas 20 5 17,40 22,37 21,31 15,98 10,66 A EU/1/98/096/005 Temodal MS cietas kapsulas 100 5 86,94 102,13 97,25 72,94 48,63 A EU/1/98/096/007 Temodal MS cietas kapsulas 250 5 204,50 233,80 222,34 166,76 111,17 A Topotecanum EU/1/96/027/003 Hycamtin SB pulveris infūziju šķīduma koncentrāta pagatavošanai 4 1 130,73 151,18 94,48 70,86 47,24 A Venlafaxinum 05-0556-01 Velaxin 37,5mg EG tabletes 37.5 28 3,75 5,25 4,97 3,73 2,49 A 05-0558-01 Velaxin 75mg EG tabletes 75 28 6,67 9,04 7,15 5,36 3,58 A Nacionālā veselības dienesta direktors M.Taube 8.pielikums Nacionālā veselības dienesta 2012.gada 3.decembra rīkojumam Nr.04.1-2/325 No Kompensējamo zāļu saraksta svītrotās medicīniskās ierīces Medicīniskā ierīce Identifikācijas Nr. Medicīniskās ierīces nosaukums Iesniedzējs Iepakojuma lielums Kompensācijas bāzes cena (Ls) Aptiekas cena ar 12% PVN (Ls) Kompensācijas summa (Ls) Saraksta kategorija Pazīme References cena 100% 50% Glikēmijas teststrēmeles 10/01-011/06-01 CareSensN BIOEKSMA UAB 50 12,21 16,05 11,20 5,60 A 10/01-010/06-01 CareSens BIOEKSMA UAB 50 12,21 16,05 11,20 5,60 A Nacionālā veselības dienesta direktors M.Taube